Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hlf
|
ENSMUSG00000003949.10 | hepatic leukemia factor |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_90358090_90358263 | Hlf | 23759 | 0.225114 | 0.73 | 3.0e-10 | Click! |
chr11_90358520_90358671 | Hlf | 23340 | 0.226369 | 0.67 | 2.1e-08 | Click! |
chr11_90363830_90364151 | Hlf | 17945 | 0.241860 | 0.67 | 2.6e-08 | Click! |
chr11_90370795_90371015 | Hlf | 11030 | 0.260680 | -0.61 | 7.7e-07 | Click! |
chr11_90418388_90418564 | Hlf | 27581 | 0.210026 | -0.56 | 7.0e-06 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_14351950_14353283 | 488.81 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr14_14354416_14355184 | 52.14 |
Il3ra |
interleukin 3 receptor, alpha chain |
5179 |
0.12 |
chr3_84350340_84350697 | 28.28 |
4930565D16Rik |
RIKEN cDNA 4930565D16 gene |
29403 |
0.19 |
chr4_62516904_62517154 | 26.48 |
Alad |
aminolevulinate, delta-, dehydratase |
2852 |
0.16 |
chr6_138424907_138425582 | 24.92 |
Lmo3 |
LIM domain only 3 |
629 |
0.69 |
chr5_144373026_144373335 | 23.98 |
Dmrt1i |
Dmrt1 interacting ncRNA |
14655 |
0.16 |
chr7_109023554_109023968 | 23.84 |
Tub |
tubby bipartite transcription factor |
3462 |
0.21 |
chr10_42265424_42265606 | 23.07 |
Foxo3 |
forkhead box O3 |
7149 |
0.26 |
chr5_123223029_123223358 | 22.87 |
Psmd9 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 9 |
4997 |
0.12 |
chr11_80713830_80713981 | 22.32 |
Myo1d |
myosin ID |
66098 |
0.11 |
chr3_60784948_60785110 | 20.94 |
Gm38326 |
predicted gene, 38326 |
3332 |
0.24 |
chr7_103811151_103811488 | 20.48 |
Hbb-bt |
hemoglobin, beta adult t chain |
2677 |
0.09 |
chr18_42510920_42511513 | 20.35 |
Tcerg1 |
transcription elongation regulator 1 (CA150) |
271 |
0.91 |
chr6_146611446_146611715 | 19.91 |
Tm7sf3 |
transmembrane 7 superfamily member 3 |
22918 |
0.11 |
chr5_124605361_124605521 | 19.15 |
Tctn2 |
tectonic family member 2 |
6644 |
0.12 |
chr1_162891926_162892449 | 19.05 |
Fmo2 |
flavin containing monooxygenase 2 |
5672 |
0.19 |
chr4_11147788_11148157 | 18.77 |
Gm11830 |
predicted gene 11830 |
3262 |
0.15 |
chr6_52225788_52226610 | 18.64 |
Hoxa9 |
homeobox A9 |
10 |
0.91 |
chr10_121796126_121796297 | 18.44 |
Srgap1 |
SLIT-ROBO Rho GTPase activating protein 1 |
10893 |
0.19 |
chr9_108338578_108339700 | 18.35 |
Gpx1 |
glutathione peroxidase 1 |
85 |
0.89 |
chr14_46539820_46540205 | 17.76 |
E130120K24Rik |
RIKEN cDNA E130120K24 gene |
16291 |
0.12 |
chr19_43464340_43464491 | 17.72 |
Gm47938 |
predicted gene, 47938 |
5343 |
0.15 |
chr2_170158021_170158172 | 17.40 |
Zfp217 |
zinc finger protein 217 |
9993 |
0.28 |
chr2_153161013_153161878 | 17.19 |
Tm9sf4 |
transmembrane 9 superfamily protein member 4 |
96 |
0.96 |
chr1_186735632_186735783 | 17.14 |
Rrp15 |
ribosomal RNA processing 15 homolog (S. cerevisiae) |
13618 |
0.13 |
chr9_64794477_64794818 | 16.85 |
Dennd4a |
DENN/MADD domain containing 4A |
16693 |
0.19 |
chr11_105905566_105905858 | 16.75 |
Tanc2 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 |
3729 |
0.17 |
chr5_100632845_100633119 | 16.61 |
Coq2 |
coenzyme Q2 4-hydroxybenzoate polyprenyltransferase |
31437 |
0.11 |
chr6_82863545_82863730 | 16.52 |
2310069B03Rik |
RIKEN cDNA 2310069B03 gene |
18195 |
0.1 |
chr3_103171228_103172264 | 16.44 |
Bcas2 |
breast carcinoma amplified sequence 2 |
3 |
0.97 |
chr17_84167487_84167639 | 16.23 |
Gm19696 |
predicted gene, 19696 |
11123 |
0.15 |
chr4_149792047_149792452 | 16.21 |
Gm13065 |
predicted gene 13065 |
1170 |
0.3 |
chr12_12941527_12942979 | 16.19 |
Mycn |
v-myc avian myelocytomatosis viral related oncogene, neuroblastoma derived |
339 |
0.83 |
chr6_83015153_83015532 | 16.17 |
M1ap |
meiosis 1 associated protein |
10996 |
0.07 |
chr5_24383104_24384088 | 16.04 |
Gm15587 |
predicted gene 15587 |
14 |
0.94 |
chr15_103258381_103258750 | 15.95 |
Nfe2 |
nuclear factor, erythroid derived 2 |
162 |
0.91 |
chr9_78217062_78217474 | 15.95 |
Gm3126 |
predicted gene 3126 |
2423 |
0.16 |
chr12_105511785_105512168 | 15.80 |
AU015791 |
expressed sequence AU015791 |
1504 |
0.38 |
chr7_81688469_81688771 | 15.77 |
Homer2 |
homer scaffolding protein 2 |
4267 |
0.16 |
chr17_79918069_79918346 | 15.70 |
Gm6552 |
predicted gene 6552 |
16365 |
0.16 |
chr13_111940877_111941182 | 15.57 |
Gm15322 |
predicted gene 15322 |
50437 |
0.1 |
chr9_70703949_70704124 | 15.54 |
Adam10 |
a disintegrin and metallopeptidase domain 10 |
25020 |
0.16 |
chr12_79557815_79558259 | 15.40 |
Rad51b |
RAD51 paralog B |
230684 |
0.02 |
chr2_22587496_22588353 | 15.36 |
Gm13341 |
predicted gene 13341 |
38 |
0.95 |
chr11_58953843_58955382 | 15.27 |
H2aw |
H2A.W histone |
73 |
0.33 |
chr14_14353319_14353777 | 15.27 |
Il3ra |
interleukin 3 receptor, alpha chain |
3927 |
0.13 |
chr11_78985199_78985350 | 15.15 |
Lgals9 |
lectin, galactose binding, soluble 9 |
328 |
0.88 |
chr10_108360055_108360333 | 15.10 |
Gm23105 |
predicted gene, 23105 |
3471 |
0.25 |
chr2_129228172_129228350 | 15.00 |
A730036I17Rik |
RIKEN cDNA A730036I17 gene |
239 |
0.84 |
chr5_121586365_121586576 | 14.98 |
Aldh2 |
aldehyde dehydrogenase 2, mitochondrial |
6804 |
0.1 |
chr3_93469654_93469962 | 14.97 |
Tchhl1 |
trichohyalin-like 1 |
1054 |
0.33 |
chr8_117692213_117692415 | 14.96 |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
9590 |
0.13 |
chr5_99994303_99994479 | 14.94 |
Gm17092 |
predicted gene 17092 |
15330 |
0.13 |
chr12_79676347_79676498 | 14.92 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
248311 |
0.02 |
chr11_53547850_53548003 | 14.81 |
Septin8 |
septin 8 |
15875 |
0.1 |
chr5_149108183_149108514 | 14.73 |
Mm2pr |
macrophage M2 polarization regulator |
15064 |
0.1 |
chr13_60680942_60681179 | 14.69 |
Dapk1 |
death associated protein kinase 1 |
15353 |
0.17 |
chr1_137010612_137010841 | 14.69 |
Gm23763 |
predicted gene, 23763 |
20456 |
0.22 |
chr14_76504101_76505194 | 14.67 |
Tsc22d1 |
TSC22 domain family, member 1 |
117 |
0.97 |
chr5_142817505_142818348 | 14.66 |
Tnrc18 |
trinucleotide repeat containing 18 |
264 |
0.91 |
chr7_79259206_79259503 | 14.61 |
Gm31510 |
predicted gene, 31510 |
13457 |
0.14 |
chr9_103007679_103008651 | 14.59 |
Slco2a1 |
solute carrier organic anion transporter family, member 2a1 |
11 |
0.97 |
chr16_87676421_87676572 | 14.52 |
Bach1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
22449 |
0.18 |
chr19_42146409_42146561 | 14.49 |
Marveld1 |
MARVEL (membrane-associating) domain containing 1 |
915 |
0.43 |
chr17_46160104_46160711 | 14.41 |
Gtpbp2 |
GTP binding protein 2 |
625 |
0.56 |
chr6_38316078_38316363 | 14.35 |
Zc3hav1l |
zinc finger CCCH-type, antiviral 1-like |
16961 |
0.13 |
chr17_26512504_26512677 | 14.16 |
Dusp1 |
dual specificity phosphatase 1 |
4071 |
0.13 |
chr13_34789311_34789480 | 14.09 |
Gm47157 |
predicted gene, 47157 |
25149 |
0.12 |
chr3_157732464_157732921 | 14.09 |
Gm33466 |
predicted gene, 33466 |
6284 |
0.26 |
chr9_98805578_98805874 | 14.09 |
E330023G01Rik |
RIKEN cDNA E330023G01 gene |
14361 |
0.11 |
chr8_122898579_122898765 | 14.08 |
Ankrd11 |
ankyrin repeat domain 11 |
1108 |
0.4 |
chr13_101692140_101693278 | 13.99 |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
79 |
0.98 |
chr10_17653857_17654030 | 13.81 |
Gm47771 |
predicted gene, 47771 |
4570 |
0.27 |
chr6_83032753_83034325 | 13.75 |
Dok1 |
docking protein 1 |
68 |
0.86 |
chr4_87805858_87806167 | 13.63 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
282 |
0.95 |
chr11_51767849_51768134 | 13.51 |
Sar1b |
secretion associated Ras related GTPase 1B |
4297 |
0.17 |
chr15_67146361_67146739 | 13.43 |
St3gal1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
17527 |
0.24 |
chr11_75046892_75047673 | 13.41 |
Gm12333 |
predicted gene 12333 |
7934 |
0.13 |
chr8_93197688_93197845 | 13.38 |
Ces1d |
carboxylesterase 1D |
11 |
0.97 |
chr2_75716191_75716375 | 13.34 |
E030042O20Rik |
RIKEN cDNA E030042O20 gene |
11513 |
0.12 |
chr8_11062439_11062618 | 13.31 |
B830042I05Rik |
RIKEN cDNA B830042I05 gene |
8518 |
0.15 |
chr13_101611824_101612000 | 13.30 |
Gm29341 |
predicted gene 29341 |
5679 |
0.22 |
chr6_87662289_87662458 | 13.30 |
Gm44097 |
predicted gene, 44097 |
4619 |
0.13 |
chr12_71932516_71932675 | 13.28 |
Daam1 |
dishevelled associated activator of morphogenesis 1 |
42865 |
0.15 |
chr3_138419364_138419542 | 13.12 |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
3958 |
0.16 |
chr4_135623188_135623705 | 13.01 |
1700029M20Rik |
RIKEN cDNA 1700029M20 gene |
3209 |
0.2 |
chr4_137244971_137245122 | 13.00 |
Gm13002 |
predicted gene 13002 |
21724 |
0.12 |
chr17_5798459_5798854 | 12.94 |
3300005D01Rik |
RIKEN cDNA 3300005D01 gene |
1 |
0.97 |
chr3_153932529_153932842 | 12.93 |
Acadm |
acyl-Coenzyme A dehydrogenase, medium chain |
2543 |
0.15 |
chr10_117301874_117302025 | 12.90 |
Lyz1 |
lysozyme 1 |
9081 |
0.14 |
chr19_15941554_15941779 | 12.89 |
Gm3329 |
predicted gene 3329 |
1944 |
0.31 |
chr1_31017458_31017792 | 12.88 |
4931428L18Rik |
RIKEN cDNA 4931428L18 gene |
17721 |
0.14 |
chr6_119137853_119138062 | 12.75 |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
29384 |
0.19 |
chr13_52831450_52831631 | 12.69 |
BB123696 |
expressed sequence BB123696 |
74335 |
0.1 |
chr10_59943401_59943994 | 12.69 |
Ddit4 |
DNA-damage-inducible transcript 4 |
8137 |
0.18 |
chr12_85705603_85705794 | 12.68 |
Gm47285 |
predicted gene, 47285 |
12865 |
0.12 |
chr15_79333444_79333618 | 12.68 |
Pla2g6 |
phospholipase A2, group VI |
5141 |
0.11 |
chr19_55643696_55643873 | 12.66 |
Tcf7l2 |
transcription factor 7 like 2, T cell specific, HMG box |
98036 |
0.08 |
chr12_103681850_103682044 | 12.65 |
Serpina16 |
serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 16 |
5808 |
0.11 |
chr10_128525093_128526268 | 12.64 |
Esyt1 |
extended synaptotagmin-like protein 1 |
188 |
0.63 |
chr12_80114135_80114615 | 12.63 |
Zfp36l1 |
zinc finger protein 36, C3H type-like 1 |
1362 |
0.27 |
chr17_12185970_12186143 | 12.59 |
Tdgf1-ps2 |
teratocarcinoma-derived growth factor, pseudogene 2 |
3865 |
0.23 |
chr6_108836229_108836560 | 12.56 |
Edem1 |
ER degradation enhancer, mannosidase alpha-like 1 |
16 |
0.98 |
chr10_94098138_94098431 | 12.54 |
Gm18391 |
predicted gene, 18391 |
144 |
0.94 |
chr18_84807405_84807556 | 12.49 |
Gm17266 |
predicted gene, 17266 |
29236 |
0.12 |
chr11_115462239_115462679 | 12.41 |
Slc16a5 |
solute carrier family 16 (monocarboxylic acid transporters), member 5 |
15 |
0.92 |
chr4_123613397_123613915 | 12.38 |
Macf1 |
microtubule-actin crosslinking factor 1 |
87 |
0.96 |
chr5_142920749_142921092 | 12.37 |
Actb |
actin, beta |
14166 |
0.14 |
chr7_25439971_25440122 | 12.35 |
Gm15495 |
predicted gene 15495 |
3417 |
0.13 |
chr1_87294458_87294622 | 12.30 |
Efhd1 |
EF hand domain containing 1 |
14686 |
0.12 |
chr6_125575147_125575338 | 12.29 |
Vwf |
Von Willebrand factor |
8991 |
0.21 |
chr2_126695400_126695562 | 12.28 |
Usp8 |
ubiquitin specific peptidase 8 |
11847 |
0.13 |
chr8_127440610_127440798 | 12.28 |
Pard3 |
par-3 family cell polarity regulator |
7042 |
0.31 |
chr3_102203291_102203459 | 12.27 |
Vangl1 |
VANGL planar cell polarity 1 |
506 |
0.48 |
chr10_68125112_68125271 | 12.27 |
Arid5b |
AT rich interactive domain 5B (MRF1-like) |
11435 |
0.25 |
chr1_21305606_21305757 | 12.23 |
Gm4956 |
predicted gene 4956 |
7369 |
0.1 |
chr8_126720623_126720806 | 12.20 |
Gm45805 |
predicted gene 45805 |
37620 |
0.18 |
chr11_117083539_117083733 | 12.15 |
Gm24323 |
predicted gene, 24323 |
2200 |
0.16 |
chr4_136186385_136186784 | 12.12 |
E2f2 |
E2F transcription factor 2 |
5801 |
0.15 |
chr5_66073877_66074050 | 12.09 |
Gm43775 |
predicted gene 43775 |
1068 |
0.4 |
chr9_90126272_90126558 | 12.05 |
Tmem41b-ps |
transmembrane protein 41B, pseudogene |
7478 |
0.15 |
chr13_112748147_112748432 | 12.04 |
Slc38a9 |
solute carrier family 38, member 9 |
12679 |
0.14 |
chr4_150007392_150007724 | 12.04 |
H6pd |
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
1465 |
0.34 |
chr3_27751571_27751754 | 12.00 |
Fndc3b |
fibronectin type III domain containing 3B |
40355 |
0.19 |
chr12_89156413_89157009 | 11.97 |
Nrxn3 |
neurexin III |
36395 |
0.21 |
chr11_21402956_21403119 | 11.95 |
Ugp2 |
UDP-glucose pyrophosphorylase 2 |
31836 |
0.11 |
chr1_140183199_140183575 | 11.92 |
Cfh |
complement component factor h |
24 |
0.98 |
chr1_191277526_191278108 | 11.89 |
Gm37168 |
predicted gene, 37168 |
10639 |
0.13 |
chr3_121531237_121531694 | 11.88 |
A530020G20Rik |
RIKEN cDNA A530020G20 gene |
154 |
0.91 |
chr13_92651097_92651373 | 11.86 |
Serinc5 |
serine incorporator 5 |
40061 |
0.15 |
chr1_60599018_60599192 | 11.86 |
Gm38388 |
predicted gene, 38388 |
2869 |
0.18 |
chr8_122321213_122321374 | 11.83 |
Zfpm1 |
zinc finger protein, multitype 1 |
12405 |
0.12 |
chr14_22019353_22019514 | 11.80 |
Lrmda |
leucine rich melanocyte differentiation associated |
279 |
0.87 |
chr11_70500499_70500650 | 11.78 |
Tm4sf5 |
transmembrane 4 superfamily member 5 |
4670 |
0.08 |
chr5_135695057_135695220 | 11.77 |
Gm16061 |
predicted gene 16061 |
3881 |
0.13 |
chr13_3659603_3659762 | 11.77 |
Gm23084 |
predicted gene, 23084 |
11145 |
0.16 |
chr6_124478389_124478627 | 11.71 |
Gm50463 |
predicted gene, 50463 |
11743 |
0.09 |
chr12_3236099_3236283 | 11.67 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
276 |
0.89 |
chr18_69922492_69922775 | 11.66 |
Ccdc68 |
coiled-coil domain containing 68 |
2793 |
0.26 |
chr2_72908469_72908814 | 11.66 |
Sp3 |
trans-acting transcription factor 3 |
32443 |
0.14 |
chr5_51825674_51825964 | 11.64 |
Gm43606 |
predicted gene 43606 |
32956 |
0.17 |
chr11_106812518_106812689 | 11.63 |
Cep95 |
centrosomal protein 95 |
277 |
0.83 |
chr1_191855059_191855511 | 11.63 |
Nek2 |
NIMA (never in mitosis gene a)-related expressed kinase 2 |
28137 |
0.12 |
chr11_79884896_79885047 | 11.62 |
Gm24454 |
predicted gene, 24454 |
8744 |
0.14 |
chr16_38433134_38433299 | 11.55 |
Pla1a |
phospholipase A1 member A |
71 |
0.96 |
chr7_16405093_16405902 | 11.54 |
Gm45508 |
predicted gene 45508 |
1235 |
0.27 |
chr13_37562665_37563032 | 11.54 |
Gm47751 |
predicted gene, 47751 |
2124 |
0.19 |
chr5_130044251_130044421 | 11.54 |
Crcp |
calcitonin gene-related peptide-receptor component protein |
2132 |
0.21 |
chr2_167043815_167044026 | 11.48 |
Znfx1 |
zinc finger, NFX1-type containing 1 |
425 |
0.69 |
chr6_128631648_128631811 | 11.47 |
Klrb1a |
killer cell lectin-like receptor subfamily B member 1A |
8196 |
0.08 |
chr5_15582149_15582564 | 11.45 |
Gm21083 |
predicted gene, 21083 |
5023 |
0.17 |
chr13_4233863_4234078 | 11.44 |
Akr1c19 |
aldo-keto reductase family 1, member C19 |
230 |
0.91 |
chr12_103764320_103764471 | 11.39 |
Serpina1d |
serine (or cysteine) peptidase inhibitor, clade A, member 1D |
9197 |
0.1 |
chr7_35821474_35821628 | 11.37 |
Gm28514 |
predicted gene 28514 |
16709 |
0.16 |
chr18_39560855_39561006 | 11.37 |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
41509 |
0.17 |
chr11_97210790_97210941 | 11.33 |
Npepps |
aminopeptidase puromycin sensitive |
1597 |
0.28 |
chr17_31901504_31901717 | 11.31 |
Gm50000 |
predicted gene, 50000 |
2432 |
0.21 |
chr11_101551830_101552448 | 11.30 |
Nbr1 |
NBR1, autophagy cargo receptor |
10 |
0.69 |
chr13_3891510_3891681 | 11.30 |
Net1 |
neuroepithelial cell transforming gene 1 |
1838 |
0.23 |
chr11_6444058_6445126 | 11.25 |
H2az2 |
H2A.Z histone variant 2 |
149 |
0.88 |
chr19_47454755_47455010 | 11.25 |
Sh3pxd2a |
SH3 and PX domains 2A |
9365 |
0.2 |
chr10_77113926_77114223 | 11.24 |
Col18a1 |
collagen, type XVIII, alpha 1 |
128 |
0.96 |
chr6_72493029_72493180 | 11.24 |
Sh2d6 |
SH2 domain containing 6 |
26911 |
0.11 |
chr6_134703019_134703308 | 11.21 |
Borcs5 |
BLOC-1 related complex subunit 5 |
1613 |
0.3 |
chr5_134326159_134326310 | 11.18 |
Mir3965 |
microRNA 3965 |
220 |
0.9 |
chr4_40828803_40829175 | 11.16 |
Mir5123 |
microRNA 5123 |
21149 |
0.1 |
chr5_147489307_147489518 | 11.12 |
Pan3 |
PAN3 poly(A) specific ribonuclease subunit |
28090 |
0.12 |
chr15_101177383_101177565 | 11.10 |
Acvr1b |
activin A receptor, type 1B |
3407 |
0.14 |
chr4_62348322_62348606 | 11.07 |
Fkbp15 |
FK506 binding protein 15 |
9969 |
0.14 |
chr7_113443683_113443834 | 11.06 |
Gm18780 |
predicted gene, 18780 |
5161 |
0.19 |
chr11_105125823_105126961 | 11.05 |
Mettl2 |
methyltransferase like 2 |
33 |
0.97 |
chr6_86471867_86472650 | 11.00 |
C87436 |
expressed sequence C87436 |
8218 |
0.08 |
chr12_83375826_83376054 | 10.99 |
Dpf3 |
D4, zinc and double PHD fingers, family 3 |
25045 |
0.22 |
chr15_81585272_81586453 | 10.90 |
Gm23880 |
predicted gene, 23880 |
271 |
0.52 |
chr18_64850466_64850770 | 10.90 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
37087 |
0.12 |
chr10_111073985_111074161 | 10.90 |
Gm48851 |
predicted gene, 48851 |
28798 |
0.14 |
chr10_124731338_124731489 | 10.88 |
Gm47839 |
predicted gene, 47839 |
114068 |
0.07 |
chr9_90277743_90277903 | 10.85 |
Tbc1d2b |
TBC1 domain family, member 2B |
7019 |
0.17 |
chr12_8829857_8830009 | 10.85 |
9930038B18Rik |
RIKEN cDNA 9930038B18 gene |
47449 |
0.11 |
chr17_27778181_27778332 | 10.83 |
Rps2-ps9 |
ribosomal protein S2, pseudogene 9 |
6123 |
0.14 |
chr1_193242293_193242617 | 10.78 |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
174 |
0.91 |
chr3_97627913_97628243 | 10.78 |
Fmo5 |
flavin containing monooxygenase 5 |
726 |
0.59 |
chr2_75716501_75716667 | 10.74 |
E030042O20Rik |
RIKEN cDNA E030042O20 gene |
11814 |
0.12 |
chr14_14596534_14596696 | 10.74 |
Gm47685 |
predicted gene, 47685 |
6669 |
0.19 |
chr19_17335202_17335427 | 10.73 |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
122 |
0.97 |
chr8_66363123_66363725 | 10.73 |
Marchf1 |
membrane associated ring-CH-type finger 1 |
22870 |
0.19 |
chr6_122782358_122782509 | 10.73 |
Slc2a3 |
solute carrier family 2 (facilitated glucose transporter), member 3 |
2476 |
0.17 |
chr13_47251178_47251338 | 10.72 |
Rnf144b |
ring finger protein 144B |
57433 |
0.11 |
chr8_48866088_48866239 | 10.71 |
Gm19744 |
predicted gene, 19744 |
10746 |
0.23 |
chr5_99284500_99284682 | 10.69 |
Gm35394 |
predicted gene, 35394 |
10496 |
0.23 |
chr1_31072920_31073361 | 10.69 |
4931428L18Rik |
RIKEN cDNA 4931428L18 gene |
23314 |
0.14 |
chr17_34586512_34587397 | 10.69 |
Notch4 |
notch 4 |
9 |
0.91 |
chr2_26957538_26957707 | 10.66 |
Rexo4 |
REX4, 3'-5' exonuclease |
1036 |
0.3 |
chr9_66626113_66626277 | 10.66 |
Usp3 |
ubiquitin specific peptidase 3 |
33053 |
0.16 |
chr14_79549319_79549478 | 10.63 |
Gm27857 |
predicted gene, 27857 |
12894 |
0.16 |
chr15_59481091_59481335 | 10.61 |
Nsmce2 |
NSE2/MMS21 homolog, SMC5-SMC6 complex SUMO ligase |
106926 |
0.06 |
chr10_99229387_99229562 | 10.59 |
Gm34574 |
predicted gene, 34574 |
568 |
0.62 |
chr11_49985109_49985277 | 10.59 |
Rasgef1c |
RasGEF domain family, member 1C |
21408 |
0.16 |
chr8_89279855_89280239 | 10.58 |
Gm5356 |
predicted pseudogene 5356 |
92487 |
0.09 |
chr9_21936672_21937290 | 10.56 |
Plppr2 |
phospholipid phosphatase related 2 |
52 |
0.94 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.0 | 21.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
4.9 | 14.7 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
4.6 | 13.7 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
4.3 | 13.0 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
4.2 | 16.8 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
4.2 | 12.6 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
4.1 | 20.4 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
3.9 | 11.6 | GO:0048769 | sarcomerogenesis(GO:0048769) |
3.8 | 19.2 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
3.6 | 10.7 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
3.5 | 42.2 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
3.4 | 10.2 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
3.4 | 13.5 | GO:0003383 | apical constriction(GO:0003383) |
3.3 | 16.6 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
3.2 | 9.7 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
3.2 | 3.2 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
3.1 | 15.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
3.0 | 9.1 | GO:0014858 | positive regulation of skeletal muscle cell proliferation(GO:0014858) |
3.0 | 12.1 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
3.0 | 9.1 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
3.0 | 9.0 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
3.0 | 8.9 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
3.0 | 68.0 | GO:0030224 | monocyte differentiation(GO:0030224) |
2.9 | 8.8 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
2.9 | 8.6 | GO:0042117 | monocyte activation(GO:0042117) |
2.8 | 8.4 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
2.8 | 16.8 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
2.8 | 5.6 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
2.8 | 8.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
2.7 | 10.9 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
2.7 | 10.9 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
2.7 | 10.7 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
2.6 | 10.6 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
2.6 | 10.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
2.6 | 12.9 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
2.6 | 2.6 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
2.5 | 10.1 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
2.5 | 7.6 | GO:0072718 | response to cisplatin(GO:0072718) |
2.5 | 7.5 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
2.5 | 7.5 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
2.5 | 7.4 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
2.4 | 9.7 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
2.4 | 12.0 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
2.4 | 4.7 | GO:0002432 | granuloma formation(GO:0002432) |
2.4 | 4.7 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
2.4 | 7.1 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
2.3 | 9.4 | GO:0042045 | epithelial fluid transport(GO:0042045) |
2.3 | 2.3 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
2.3 | 9.1 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
2.3 | 2.3 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
2.3 | 9.0 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
2.3 | 6.8 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
2.3 | 4.5 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
2.2 | 18.0 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
2.2 | 6.7 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
2.2 | 6.7 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
2.2 | 8.9 | GO:0009597 | detection of virus(GO:0009597) |
2.2 | 8.8 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
2.2 | 10.9 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
2.2 | 8.7 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
2.1 | 6.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
2.1 | 6.4 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
2.1 | 6.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
2.1 | 10.4 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
2.0 | 6.1 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
2.0 | 6.0 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
2.0 | 14.0 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
2.0 | 8.0 | GO:0032898 | neurotrophin production(GO:0032898) |
2.0 | 6.0 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
2.0 | 7.9 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
2.0 | 19.7 | GO:0009404 | toxin metabolic process(GO:0009404) |
2.0 | 5.9 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
2.0 | 2.0 | GO:1905038 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) |
2.0 | 11.7 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
2.0 | 2.0 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
1.9 | 9.7 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
1.9 | 3.9 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
1.9 | 5.8 | GO:0070836 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
1.9 | 13.4 | GO:0060613 | fat pad development(GO:0060613) |
1.9 | 3.8 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
1.9 | 5.7 | GO:0035483 | gastric emptying(GO:0035483) |
1.9 | 11.4 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
1.9 | 7.5 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
1.9 | 13.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
1.9 | 5.6 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
1.9 | 3.7 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.9 | 3.7 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.9 | 1.9 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
1.8 | 7.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.8 | 5.5 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
1.8 | 7.3 | GO:0034214 | protein hexamerization(GO:0034214) |
1.8 | 9.1 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
1.8 | 5.4 | GO:0040031 | snRNA modification(GO:0040031) |
1.8 | 3.6 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
1.8 | 1.8 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
1.8 | 10.8 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
1.8 | 5.4 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.8 | 1.8 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
1.8 | 1.8 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
1.8 | 3.5 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
1.8 | 7.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
1.7 | 15.7 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
1.7 | 5.2 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
1.7 | 7.0 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
1.7 | 15.6 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
1.7 | 10.4 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
1.7 | 6.9 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.7 | 10.2 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
1.7 | 1.7 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
1.7 | 1.7 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
1.6 | 8.2 | GO:0043305 | negative regulation of mast cell degranulation(GO:0043305) |
1.6 | 4.9 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.6 | 6.5 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
1.6 | 6.5 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
1.6 | 3.3 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
1.6 | 4.9 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
1.6 | 6.5 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
1.6 | 3.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.6 | 6.4 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
1.6 | 4.8 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
1.6 | 6.4 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
1.6 | 6.4 | GO:0009180 | purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
1.6 | 14.2 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
1.6 | 15.8 | GO:0030049 | muscle filament sliding(GO:0030049) |
1.6 | 7.8 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
1.6 | 10.9 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
1.6 | 12.5 | GO:0030449 | regulation of complement activation(GO:0030449) |
1.6 | 15.6 | GO:0031507 | heterochromatin assembly(GO:0031507) |
1.6 | 6.2 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
1.5 | 3.1 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
1.5 | 1.5 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
1.5 | 1.5 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
1.5 | 4.6 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
1.5 | 1.5 | GO:0003166 | bundle of His development(GO:0003166) |
1.5 | 4.6 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
1.5 | 3.0 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
1.5 | 6.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.5 | 7.5 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
1.5 | 1.5 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
1.5 | 1.5 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
1.5 | 3.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.5 | 7.4 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
1.5 | 1.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.5 | 4.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.4 | 10.1 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
1.4 | 14.4 | GO:0019985 | translesion synthesis(GO:0019985) |
1.4 | 2.9 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
1.4 | 2.9 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.4 | 11.4 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
1.4 | 10.0 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
1.4 | 1.4 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
1.4 | 8.5 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
1.4 | 11.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
1.4 | 7.0 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
1.4 | 1.4 | GO:0006901 | vesicle coating(GO:0006901) vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
1.4 | 6.8 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
1.4 | 4.1 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.4 | 6.8 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
1.4 | 5.4 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
1.4 | 1.4 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
1.4 | 5.4 | GO:0018343 | protein farnesylation(GO:0018343) |
1.3 | 13.5 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
1.3 | 5.4 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
1.3 | 5.4 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.3 | 2.7 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
1.3 | 4.0 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
1.3 | 4.0 | GO:0046040 | IMP metabolic process(GO:0046040) |
1.3 | 5.3 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
1.3 | 4.0 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
1.3 | 10.5 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.3 | 5.2 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
1.3 | 7.8 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
1.3 | 7.8 | GO:0015684 | ferrous iron transport(GO:0015684) |
1.3 | 3.9 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
1.3 | 2.6 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
1.3 | 12.8 | GO:0050872 | white fat cell differentiation(GO:0050872) |
1.3 | 5.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
1.3 | 2.5 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
1.3 | 10.0 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
1.3 | 3.8 | GO:1990928 | response to amino acid starvation(GO:1990928) |
1.3 | 3.8 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
1.3 | 7.5 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
1.2 | 3.7 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
1.2 | 2.5 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
1.2 | 8.6 | GO:0032328 | alanine transport(GO:0032328) |
1.2 | 3.7 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.2 | 3.7 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.2 | 6.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
1.2 | 3.7 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
1.2 | 7.4 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
1.2 | 7.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.2 | 1.2 | GO:0042908 | xenobiotic transport(GO:0042908) |
1.2 | 8.4 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
1.2 | 2.4 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
1.2 | 3.6 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
1.2 | 3.6 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
1.2 | 5.9 | GO:0032621 | interleukin-18 production(GO:0032621) |
1.2 | 2.3 | GO:1901524 | regulation of macromitophagy(GO:1901524) |
1.2 | 3.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.2 | 3.5 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
1.2 | 3.5 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
1.2 | 22.0 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
1.1 | 2.3 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
1.1 | 6.9 | GO:0006477 | protein sulfation(GO:0006477) |
1.1 | 3.4 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
1.1 | 3.4 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
1.1 | 4.6 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
1.1 | 3.4 | GO:0015817 | histidine transport(GO:0015817) |
1.1 | 10.3 | GO:0051197 | positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
1.1 | 2.3 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.1 | 1.1 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
1.1 | 3.4 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
1.1 | 7.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
1.1 | 3.4 | GO:0006116 | NADH oxidation(GO:0006116) |
1.1 | 12.4 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
1.1 | 2.3 | GO:0009804 | coumarin metabolic process(GO:0009804) |
1.1 | 4.5 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
1.1 | 5.6 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
1.1 | 2.3 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
1.1 | 5.6 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
1.1 | 3.4 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
1.1 | 2.2 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
1.1 | 2.2 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
1.1 | 4.4 | GO:0015886 | heme transport(GO:0015886) |
1.1 | 3.3 | GO:0043622 | cortical microtubule organization(GO:0043622) |
1.1 | 4.4 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
1.1 | 8.8 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
1.1 | 7.7 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
1.1 | 9.9 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
1.1 | 2.2 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
1.1 | 4.4 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
1.1 | 2.2 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
1.1 | 3.3 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
1.1 | 2.2 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
1.1 | 4.4 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
1.1 | 9.9 | GO:0009299 | mRNA transcription(GO:0009299) |
1.1 | 1.1 | GO:1901656 | glycoside transport(GO:1901656) |
1.1 | 1.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
1.1 | 3.3 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
1.1 | 4.3 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
1.1 | 3.3 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.1 | 3.3 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
1.1 | 3.3 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
1.1 | 7.6 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
1.1 | 6.5 | GO:0015871 | choline transport(GO:0015871) |
1.1 | 3.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
1.1 | 19.5 | GO:0015732 | prostaglandin transport(GO:0015732) |
1.1 | 6.5 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
1.1 | 3.2 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
1.1 | 1.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
1.1 | 3.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.1 | 3.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
1.1 | 6.4 | GO:0051451 | myoblast migration(GO:0051451) |
1.1 | 6.4 | GO:0042447 | hormone catabolic process(GO:0042447) |
1.1 | 4.3 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
1.1 | 4.3 | GO:0051031 | tRNA transport(GO:0051031) |
1.1 | 3.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
1.1 | 4.2 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
1.1 | 3.2 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
1.1 | 1.1 | GO:0003164 | His-Purkinje system development(GO:0003164) |
1.0 | 2.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.0 | 16.8 | GO:0032801 | receptor catabolic process(GO:0032801) |
1.0 | 2.1 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
1.0 | 4.2 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
1.0 | 5.2 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
1.0 | 7.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
1.0 | 3.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
1.0 | 4.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
1.0 | 3.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
1.0 | 4.1 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
1.0 | 1.0 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
1.0 | 4.1 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
1.0 | 13.2 | GO:0006783 | heme biosynthetic process(GO:0006783) |
1.0 | 1.0 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
1.0 | 3.0 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.0 | 2.0 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
1.0 | 4.0 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
1.0 | 7.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
1.0 | 3.0 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.0 | 3.0 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
1.0 | 3.0 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
1.0 | 1.0 | GO:0061724 | lipophagy(GO:0061724) |
1.0 | 3.9 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
1.0 | 5.9 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
1.0 | 2.0 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
1.0 | 1.0 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
1.0 | 5.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
1.0 | 2.0 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
1.0 | 2.0 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
1.0 | 1.0 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.0 | 7.8 | GO:0007097 | nuclear migration(GO:0007097) |
1.0 | 1.9 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
1.0 | 2.9 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.0 | 6.7 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
1.0 | 1.9 | GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
1.0 | 5.8 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
1.0 | 2.9 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
1.0 | 2.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.0 | 3.8 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
1.0 | 4.8 | GO:0044351 | macropinocytosis(GO:0044351) |
1.0 | 19.2 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.9 | 3.8 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.9 | 2.8 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.9 | 5.7 | GO:0097421 | liver regeneration(GO:0097421) |
0.9 | 2.8 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.9 | 1.9 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.9 | 6.6 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.9 | 2.8 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.9 | 3.7 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.9 | 0.9 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.9 | 0.9 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.9 | 6.5 | GO:0019682 | glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.9 | 3.7 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.9 | 2.8 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.9 | 3.7 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.9 | 0.9 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.9 | 3.7 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.9 | 2.8 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.9 | 2.8 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.9 | 1.8 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
0.9 | 0.9 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.9 | 1.8 | GO:0045472 | response to ether(GO:0045472) |
0.9 | 1.8 | GO:0003032 | detection of oxygen(GO:0003032) |
0.9 | 5.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.9 | 0.9 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.9 | 3.6 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.9 | 1.8 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.9 | 1.8 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.9 | 3.6 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.9 | 0.9 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.9 | 1.8 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.9 | 2.7 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.9 | 0.9 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.9 | 8.1 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.9 | 0.9 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.9 | 2.7 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.9 | 2.7 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.9 | 5.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.9 | 0.9 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.9 | 2.7 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.9 | 2.6 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.9 | 2.6 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.9 | 3.5 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.9 | 1.7 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.9 | 0.9 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.9 | 0.9 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.9 | 0.9 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.9 | 0.9 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.9 | 10.3 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.9 | 2.6 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.9 | 8.6 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.9 | 0.9 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.9 | 1.7 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.9 | 0.9 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.9 | 1.7 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.9 | 2.6 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.9 | 2.6 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.9 | 11.1 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.8 | 7.6 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.8 | 5.9 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.8 | 4.2 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.8 | 0.8 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.8 | 0.8 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.8 | 2.5 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.8 | 4.2 | GO:0046836 | glycolipid transport(GO:0046836) |
0.8 | 6.7 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.8 | 6.7 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.8 | 2.5 | GO:1905049 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.8 | 2.5 | GO:0015888 | thiamine transport(GO:0015888) |
0.8 | 1.7 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.8 | 2.5 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.8 | 4.2 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.8 | 2.5 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.8 | 17.4 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.8 | 0.8 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.8 | 5.0 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.8 | 2.5 | GO:2000739 | regulation of mesenchymal stem cell differentiation(GO:2000739) |
0.8 | 3.3 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.8 | 5.7 | GO:0000012 | single strand break repair(GO:0000012) |
0.8 | 1.6 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.8 | 4.1 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.8 | 9.8 | GO:0051601 | exocyst localization(GO:0051601) |
0.8 | 1.6 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.8 | 2.4 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.8 | 0.8 | GO:0070922 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) small RNA loading onto RISC(GO:0070922) |
0.8 | 2.4 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.8 | 2.4 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.8 | 4.8 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.8 | 14.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.8 | 2.4 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.8 | 2.4 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.8 | 2.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.8 | 3.2 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.8 | 2.4 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.8 | 0.8 | GO:0009080 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
0.8 | 4.8 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.8 | 4.0 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.8 | 1.6 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.8 | 2.4 | GO:0032782 | bile acid secretion(GO:0032782) |
0.8 | 0.8 | GO:0035973 | aggrephagy(GO:0035973) |
0.8 | 7.1 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.8 | 1.6 | GO:0002215 | defense response to nematode(GO:0002215) |
0.8 | 2.3 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.8 | 3.1 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.8 | 0.8 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.8 | 3.9 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.8 | 17.8 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.8 | 3.9 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.8 | 1.6 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.8 | 0.8 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.8 | 4.6 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.8 | 3.1 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.8 | 2.3 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.8 | 2.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.8 | 6.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.8 | 1.5 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.8 | 0.8 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.8 | 2.3 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.8 | 1.5 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.8 | 4.6 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.8 | 5.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.8 | 1.5 | GO:0032439 | endosome localization(GO:0032439) |
0.8 | 1.5 | GO:0030242 | pexophagy(GO:0030242) |
0.8 | 7.6 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.8 | 4.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.8 | 0.8 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.8 | 0.8 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.8 | 5.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.8 | 0.8 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.8 | 0.8 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.8 | 0.8 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.7 | 2.2 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.7 | 2.2 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.7 | 5.2 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.7 | 5.9 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.7 | 3.0 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.7 | 1.5 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.7 | 5.9 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.7 | 14.1 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.7 | 4.4 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.7 | 2.2 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.7 | 5.9 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.7 | 0.7 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.7 | 8.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.7 | 2.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.7 | 1.5 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.7 | 2.9 | GO:0018101 | protein citrullination(GO:0018101) |
0.7 | 5.1 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.7 | 1.4 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.7 | 0.7 | GO:0000338 | protein deneddylation(GO:0000338) |
0.7 | 4.3 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.7 | 5.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.7 | 2.2 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.7 | 2.9 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.7 | 4.3 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.7 | 0.7 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.7 | 7.9 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.7 | 1.4 | GO:0016264 | gap junction assembly(GO:0016264) |
0.7 | 5.0 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.7 | 2.9 | GO:1903273 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
0.7 | 7.2 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
0.7 | 0.7 | GO:0046271 | phenylpropanoid metabolic process(GO:0009698) phenylpropanoid catabolic process(GO:0046271) |
0.7 | 2.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.7 | 4.3 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.7 | 1.4 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.7 | 1.4 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.7 | 2.9 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.7 | 2.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.7 | 2.1 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.7 | 0.7 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.7 | 2.1 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.7 | 2.1 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.7 | 1.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.7 | 4.2 | GO:0015677 | copper ion import(GO:0015677) |
0.7 | 1.4 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.7 | 2.1 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.7 | 1.4 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.7 | 2.8 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.7 | 4.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.7 | 2.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.7 | 0.7 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.7 | 2.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.7 | 1.4 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.7 | 4.9 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.7 | 1.4 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.7 | 2.8 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.7 | 1.4 | GO:0001705 | ectoderm formation(GO:0001705) |
0.7 | 2.7 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.7 | 2.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.7 | 6.8 | GO:0052472 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.7 | 1.4 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.7 | 2.7 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.7 | 2.7 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.7 | 0.7 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.7 | 2.0 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.7 | 1.4 | GO:0048102 | autophagic cell death(GO:0048102) |
0.7 | 3.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.7 | 0.7 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.7 | 1.3 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.7 | 2.7 | GO:1902743 | regulation of lamellipodium organization(GO:1902743) |
0.7 | 1.3 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.7 | 0.7 | GO:0010225 | response to UV-C(GO:0010225) |
0.7 | 3.3 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.7 | 2.0 | GO:0036394 | amylase secretion(GO:0036394) |
0.7 | 8.6 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.7 | 4.6 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.7 | 4.6 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.7 | 0.7 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.7 | 5.2 | GO:0048821 | erythrocyte development(GO:0048821) |
0.7 | 2.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.7 | 1.3 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.7 | 2.0 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.7 | 3.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.6 | 1.9 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.6 | 2.6 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.6 | 0.6 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.6 | 0.6 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.6 | 1.9 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.6 | 8.3 | GO:0017144 | drug metabolic process(GO:0017144) |
0.6 | 6.4 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.6 | 1.3 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.6 | 5.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.6 | 1.9 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.6 | 19.6 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.6 | 10.1 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.6 | 0.6 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.6 | 1.3 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.6 | 1.9 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.6 | 7.5 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.6 | 0.6 | GO:0070384 | Harderian gland development(GO:0070384) |
0.6 | 5.6 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.6 | 1.9 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.6 | 1.9 | GO:0061511 | centriole elongation(GO:0061511) |
0.6 | 0.6 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.6 | 2.5 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.6 | 1.9 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.6 | 2.5 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.6 | 2.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.6 | 3.1 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.6 | 1.8 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.6 | 1.8 | GO:0019086 | late viral transcription(GO:0019086) |
0.6 | 2.4 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.6 | 1.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.6 | 7.9 | GO:0032094 | response to food(GO:0032094) |
0.6 | 3.6 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.6 | 1.8 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.6 | 3.0 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.6 | 5.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.6 | 1.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.6 | 1.8 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.6 | 2.4 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.6 | 1.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.6 | 4.8 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.6 | 4.8 | GO:0051444 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.6 | 2.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.6 | 1.8 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.6 | 1.8 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.6 | 0.6 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.6 | 3.0 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.6 | 9.6 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.6 | 3.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.6 | 1.2 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.6 | 3.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.6 | 1.8 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.6 | 0.6 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.6 | 0.6 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.6 | 3.6 | GO:0006301 | postreplication repair(GO:0006301) |
0.6 | 0.6 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.6 | 5.9 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.6 | 2.9 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.6 | 1.2 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.6 | 3.5 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.6 | 1.8 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.6 | 2.3 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.6 | 0.6 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.6 | 2.9 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.6 | 1.2 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.6 | 0.6 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.6 | 1.7 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.6 | 1.2 | GO:0035733 | hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) |
0.6 | 0.6 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.6 | 15.0 | GO:0006953 | acute-phase response(GO:0006953) |
0.6 | 2.9 | GO:0001842 | neural fold formation(GO:0001842) |
0.6 | 2.3 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.6 | 1.7 | GO:0030913 | protein localization to paranode region of axon(GO:0002175) paranodal junction assembly(GO:0030913) |
0.6 | 4.6 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.6 | 0.6 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.6 | 2.9 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.6 | 0.6 | GO:0060463 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.6 | 4.0 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.6 | 1.7 | GO:0015682 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
0.6 | 2.8 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.6 | 10.8 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.6 | 1.7 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.6 | 1.1 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.6 | 2.8 | GO:0007144 | female meiosis I(GO:0007144) |
0.6 | 1.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.6 | 1.7 | GO:0048478 | replication fork protection(GO:0048478) |
0.6 | 0.6 | GO:1902896 | terminal web assembly(GO:1902896) |
0.6 | 16.3 | GO:0006721 | terpenoid metabolic process(GO:0006721) |
0.6 | 1.1 | GO:0015893 | drug transport(GO:0015893) |
0.6 | 2.2 | GO:0090195 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) |
0.6 | 6.2 | GO:0051642 | centrosome localization(GO:0051642) |
0.6 | 4.5 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.6 | 1.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.6 | 19.5 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.6 | 3.9 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.6 | 4.5 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.6 | 2.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.6 | 1.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.6 | 2.2 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.6 | 1.7 | GO:0071029 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
0.6 | 3.9 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.5 | 7.1 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.5 | 3.3 | GO:0030220 | platelet formation(GO:0030220) |
0.5 | 2.2 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.5 | 4.9 | GO:1901890 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) |
0.5 | 5.4 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.5 | 4.3 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.5 | 1.6 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.5 | 1.1 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
0.5 | 1.1 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.5 | 3.8 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.5 | 2.7 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.5 | 5.9 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.5 | 2.2 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.5 | 1.6 | GO:0032570 | response to progesterone(GO:0032570) |
0.5 | 1.6 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.5 | 2.1 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.5 | 3.2 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.5 | 1.1 | GO:0060921 | sinoatrial node cell differentiation(GO:0060921) |
0.5 | 12.8 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.5 | 3.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.5 | 3.7 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.5 | 5.8 | GO:0046460 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.5 | 0.5 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.5 | 3.2 | GO:1900116 | sequestering of extracellular ligand from receptor(GO:0035581) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.5 | 2.6 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.5 | 0.5 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.5 | 6.8 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.5 | 9.4 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.5 | 4.2 | GO:0030575 | nuclear body organization(GO:0030575) |
0.5 | 0.5 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.5 | 5.8 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.5 | 0.5 | GO:0043302 | positive regulation of leukocyte degranulation(GO:0043302) |
0.5 | 3.7 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.5 | 1.0 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.5 | 0.5 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.5 | 0.5 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.5 | 2.1 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.5 | 2.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.5 | 0.5 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.5 | 4.7 | GO:0002931 | response to ischemia(GO:0002931) |
0.5 | 3.1 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.5 | 3.6 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.5 | 0.5 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.5 | 4.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.5 | 1.0 | GO:0048793 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) pronephros development(GO:0048793) |
0.5 | 1.5 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.5 | 4.6 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.5 | 1.0 | GO:0061084 | negative regulation of protein refolding(GO:0061084) |
0.5 | 4.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.5 | 1.0 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.5 | 2.0 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.5 | 1.5 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.5 | 6.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.5 | 1.5 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.5 | 0.5 | GO:0045346 | regulation of MHC class II biosynthetic process(GO:0045346) |
0.5 | 0.5 | GO:0008354 | germ cell migration(GO:0008354) |
0.5 | 0.5 | GO:0070831 | basement membrane assembly(GO:0070831) regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.5 | 1.0 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.5 | 0.5 | GO:0030258 | lipid modification(GO:0030258) |
0.5 | 0.5 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.5 | 5.0 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.5 | 0.5 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.5 | 3.0 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.5 | 1.0 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.5 | 3.5 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.5 | 3.0 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.5 | 1.5 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.5 | 1.5 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.5 | 3.9 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.5 | 1.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.5 | 2.0 | GO:0060068 | vagina development(GO:0060068) |
0.5 | 1.5 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.5 | 4.4 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.5 | 2.9 | GO:0007398 | ectoderm development(GO:0007398) |
0.5 | 0.5 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.5 | 15.6 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.5 | 0.5 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.5 | 1.9 | GO:0051639 | actin filament network formation(GO:0051639) |
0.5 | 2.9 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.5 | 4.3 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.5 | 2.4 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.5 | 1.4 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.5 | 1.4 | GO:0007296 | vitellogenesis(GO:0007296) |
0.5 | 2.4 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.5 | 0.5 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.5 | 0.5 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.5 | 0.5 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.5 | 1.4 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.5 | 0.5 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.5 | 18.1 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.5 | 1.4 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.5 | 1.4 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.5 | 1.0 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.5 | 1.9 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.5 | 0.9 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.5 | 1.4 | GO:1903236 | regulation of leukocyte tethering or rolling(GO:1903236) |
0.5 | 1.4 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.5 | 0.9 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.5 | 1.4 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.5 | 1.4 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.5 | 0.5 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.5 | 6.6 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.5 | 2.3 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.5 | 0.5 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.5 | 1.9 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.5 | 2.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.5 | 0.9 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.5 | 1.9 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.5 | 3.7 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.5 | 0.9 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.5 | 0.5 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.5 | 2.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.5 | 1.8 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.5 | 7.4 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.5 | 3.7 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.5 | 1.4 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.5 | 2.3 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.5 | 1.4 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.5 | 5.0 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.5 | 1.8 | GO:0042637 | catagen(GO:0042637) |
0.5 | 1.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.5 | 3.6 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.5 | 0.5 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.5 | 1.8 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.4 | 3.6 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.4 | 0.9 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.4 | 1.3 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
0.4 | 5.8 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.4 | 1.8 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.4 | 0.9 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.4 | 0.4 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.4 | 2.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.4 | 3.1 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.4 | 0.4 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.4 | 1.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.4 | 3.1 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.4 | 0.4 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.4 | 0.9 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.4 | 0.9 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.4 | 1.8 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.4 | 1.3 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.4 | 4.0 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
0.4 | 0.9 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.4 | 1.3 | GO:0031100 | organ regeneration(GO:0031100) |
0.4 | 0.4 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.4 | 1.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.4 | 0.9 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.4 | 0.9 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.4 | 20.0 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.4 | 0.9 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.4 | 0.9 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.4 | 4.3 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.4 | 1.7 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.4 | 8.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.4 | 0.9 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.4 | 11.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.4 | 0.9 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
0.4 | 1.3 | GO:0030431 | sleep(GO:0030431) |
0.4 | 10.7 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.4 | 0.9 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.4 | 0.9 | GO:0044851 | hair cycle phase(GO:0044851) |
0.4 | 0.9 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.4 | 1.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.4 | 3.8 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.4 | 4.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.4 | 0.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.4 | 1.3 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.4 | 1.7 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.4 | 0.4 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.4 | 0.8 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.4 | 0.8 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.4 | 2.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.4 | 0.8 | GO:0010998 | regulation of translational initiation by eIF2 alpha phosphorylation(GO:0010998) regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.4 | 6.7 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.4 | 0.8 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.4 | 1.3 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.4 | 6.3 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.4 | 1.3 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
0.4 | 1.7 | GO:0036233 | glycine import(GO:0036233) |
0.4 | 0.8 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.4 | 0.4 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.4 | 0.4 | GO:0045005 | replication fork processing(GO:0031297) DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.4 | 0.8 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.4 | 13.3 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.4 | 0.4 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.4 | 1.2 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.4 | 0.8 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) negative regulation of ribosome biogenesis(GO:0090071) |
0.4 | 1.7 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.4 | 3.7 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.4 | 1.7 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.4 | 1.2 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.4 | 10.3 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.4 | 2.1 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.4 | 6.2 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) circadian sleep/wake cycle, sleep(GO:0050802) |
0.4 | 5.7 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.4 | 0.4 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.4 | 0.8 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.4 | 0.8 | GO:0070268 | cornification(GO:0070268) |
0.4 | 0.8 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.4 | 0.8 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.4 | 0.8 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.4 | 2.4 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.4 | 2.0 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.4 | 1.2 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
0.4 | 14.1 | GO:0043038 | amino acid activation(GO:0043038) |
0.4 | 0.8 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.4 | 0.8 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.4 | 2.0 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.4 | 0.8 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.4 | 2.0 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.4 | 0.4 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.4 | 0.4 | GO:1902075 | cellular response to salt(GO:1902075) |
0.4 | 3.2 | GO:0006825 | copper ion transport(GO:0006825) |
0.4 | 1.2 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.4 | 2.0 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.4 | 0.4 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.4 | 0.8 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.4 | 1.2 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.4 | 1.2 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.4 | 0.8 | GO:0006848 | pyruvate transport(GO:0006848) |
0.4 | 0.8 | GO:0070293 | renal absorption(GO:0070293) |
0.4 | 2.3 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.4 | 1.2 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.4 | 5.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.4 | 1.6 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.4 | 1.2 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.4 | 0.8 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.4 | 2.3 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.4 | 0.8 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.4 | 2.7 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.4 | 0.8 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.4 | 1.9 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.4 | 0.8 | GO:0051775 | response to redox state(GO:0051775) |
0.4 | 3.4 | GO:0033273 | response to vitamin(GO:0033273) |
0.4 | 2.7 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.4 | 1.1 | GO:0015884 | folic acid transport(GO:0015884) |
0.4 | 0.4 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.4 | 1.1 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.4 | 0.8 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.4 | 0.8 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.4 | 0.4 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.4 | 3.8 | GO:0048535 | lymph node development(GO:0048535) |
0.4 | 0.4 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.4 | 0.8 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.4 | 0.4 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.4 | 1.1 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.4 | 2.6 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.4 | 0.4 | GO:0010226 | response to lithium ion(GO:0010226) |
0.4 | 1.1 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
0.4 | 3.0 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.4 | 0.7 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.4 | 0.7 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.4 | 0.4 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.4 | 0.4 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.4 | 0.4 | GO:0034637 | cellular carbohydrate biosynthetic process(GO:0034637) |
0.4 | 0.7 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.4 | 3.3 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.4 | 2.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.4 | 1.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.4 | 1.1 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.4 | 3.3 | GO:0014850 | response to muscle activity(GO:0014850) |
0.4 | 7.3 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.4 | 1.1 | GO:0060065 | uterus development(GO:0060065) |
0.4 | 0.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.4 | 2.2 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.4 | 4.7 | GO:0045116 | protein neddylation(GO:0045116) |
0.4 | 0.4 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.4 | 0.7 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.4 | 0.4 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.4 | 5.0 | GO:0048538 | thymus development(GO:0048538) |
0.4 | 0.4 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.4 | 0.7 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.4 | 0.7 | GO:0000087 | mitotic M phase(GO:0000087) mitotic cell cycle phase(GO:0098763) |
0.4 | 10.0 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.4 | 2.5 | GO:0007141 | male meiosis I(GO:0007141) |
0.4 | 2.1 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.4 | 2.8 | GO:0016322 | neuron remodeling(GO:0016322) |
0.4 | 3.2 | GO:0006956 | complement activation(GO:0006956) |
0.4 | 0.4 | GO:0002021 | response to dietary excess(GO:0002021) |
0.4 | 0.4 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.4 | 1.1 | GO:0003283 | atrial septum development(GO:0003283) |
0.4 | 1.8 | GO:0009249 | protein lipoylation(GO:0009249) |
0.4 | 1.1 | GO:0061042 | vascular wound healing(GO:0061042) |
0.4 | 0.4 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.4 | 2.5 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.4 | 0.4 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.3 | 0.7 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.3 | 1.7 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.3 | 1.7 | GO:0002507 | tolerance induction(GO:0002507) |
0.3 | 0.7 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.3 | 0.7 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
0.3 | 0.7 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.3 | 2.8 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.3 | 8.6 | GO:0048144 | fibroblast proliferation(GO:0048144) |
0.3 | 1.7 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.3 | 2.1 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.3 | 0.3 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.3 | 0.3 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.3 | 3.4 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.3 | 1.0 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.3 | 1.0 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.3 | 1.4 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.3 | 1.7 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.3 | 0.7 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.3 | 0.7 | GO:0032252 | secretory granule localization(GO:0032252) |
0.3 | 4.7 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.3 | 0.7 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.3 | 2.0 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.3 | 0.7 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.3 | 1.0 | GO:0006108 | malate metabolic process(GO:0006108) |
0.3 | 2.0 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.3 | 1.3 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.3 | 1.7 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.3 | 0.3 | GO:0007525 | somatic muscle development(GO:0007525) |
0.3 | 5.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.3 | 3.0 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.3 | 0.3 | GO:0034505 | tooth mineralization(GO:0034505) |
0.3 | 0.7 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.3 | 0.3 | GO:0001993 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.3 | 0.3 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.3 | 0.7 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.3 | 1.6 | GO:0014823 | response to activity(GO:0014823) |
0.3 | 0.7 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.3 | 2.0 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.3 | 0.7 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.3 | 0.6 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.3 | 3.9 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.3 | 0.3 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.3 | 24.3 | GO:0098779 | macromitophagy(GO:0000423) mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
0.3 | 1.6 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.3 | 1.0 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.3 | 2.3 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.3 | 1.3 | GO:0097435 | fibril organization(GO:0097435) |
0.3 | 1.0 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.3 | 1.0 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.3 | 1.3 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.3 | 1.9 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.3 | 1.6 | GO:0009648 | photoperiodism(GO:0009648) |
0.3 | 0.3 | GO:0032493 | response to bacterial lipoprotein(GO:0032493) |
0.3 | 2.2 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.3 | 1.3 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.3 | 0.6 | GO:0019081 | viral translation(GO:0019081) |
0.3 | 0.6 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.3 | 0.9 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.3 | 0.3 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.3 | 2.2 | GO:0042026 | protein refolding(GO:0042026) |
0.3 | 3.1 | GO:0097186 | amelogenesis(GO:0097186) |
0.3 | 0.3 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.3 | 0.6 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.3 | 0.3 | GO:0035360 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.3 | 0.9 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.3 | 0.3 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.3 | 1.2 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.3 | 0.3 | GO:0032831 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.3 | 0.6 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.3 | 0.3 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.3 | 0.3 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.3 | 10.2 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.3 | 0.9 | GO:0006415 | translational termination(GO:0006415) |
0.3 | 0.3 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.3 | 1.8 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.3 | 3.7 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.3 | 0.3 | GO:0015747 | urate transport(GO:0015747) |
0.3 | 1.5 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.3 | 0.3 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.3 | 0.6 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.3 | 1.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.3 | 0.6 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.3 | 1.2 | GO:0009650 | UV protection(GO:0009650) |
0.3 | 0.3 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.3 | 0.3 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.3 | 0.9 | GO:0015819 | lysine transport(GO:0015819) |
0.3 | 0.3 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.3 | 1.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.3 | 0.3 | GO:0060100 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.3 | 8.0 | GO:0051306 | mitotic sister chromatid separation(GO:0051306) |
0.3 | 0.6 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.3 | 10.4 | GO:0050709 | negative regulation of protein secretion(GO:0050709) |
0.3 | 0.6 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
0.3 | 0.3 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.3 | 0.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.3 | 6.2 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.3 | 3.2 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.3 | 6.4 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.3 | 0.3 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.3 | 1.5 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.3 | 0.9 | GO:0034340 | response to type I interferon(GO:0034340) |
0.3 | 0.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 1.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.3 | 0.3 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.3 | 8.4 | GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043280) |
0.3 | 0.9 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.3 | 2.0 | GO:0010950 | positive regulation of endopeptidase activity(GO:0010950) |
0.3 | 0.9 | GO:0090493 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.3 | 1.4 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.3 | 1.4 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.3 | 1.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.3 | 0.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.3 | 0.6 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.3 | 1.4 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.3 | 0.9 | GO:0036230 | granulocyte activation(GO:0036230) |
0.3 | 0.6 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
0.3 | 1.4 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.3 | 0.9 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.3 | 0.8 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.3 | 0.3 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.3 | 0.8 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.3 | 0.6 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.3 | 3.9 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.3 | 0.3 | GO:0072111 | cell proliferation involved in kidney development(GO:0072111) |
0.3 | 1.1 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.3 | 0.8 | GO:0015867 | ATP transport(GO:0015867) |
0.3 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.3 | 2.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.3 | 0.6 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.3 | 0.3 | GO:0070368 | regulation of hepatocyte differentiation(GO:0070366) positive regulation of hepatocyte differentiation(GO:0070368) |
0.3 | 8.9 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.3 | 0.3 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.3 | 1.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.3 | 1.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.3 | 1.1 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.3 | 2.5 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.3 | 3.0 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.3 | 0.5 | GO:0046931 | pore complex assembly(GO:0046931) |
0.3 | 2.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.3 | 0.3 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.3 | 2.7 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.3 | 2.5 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.3 | 1.1 | GO:1900744 | regulation of p38MAPK cascade(GO:1900744) |
0.3 | 1.1 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.3 | 0.8 | GO:0015825 | L-serine transport(GO:0015825) |
0.3 | 0.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.3 | 0.3 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
0.3 | 0.8 | GO:2000515 | negative regulation of CD4-positive, alpha-beta T cell activation(GO:2000515) |
0.3 | 3.3 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.3 | 1.3 | GO:0009124 | nucleoside monophosphate biosynthetic process(GO:0009124) |
0.3 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.3 | 1.9 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.3 | 0.8 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.3 | 0.3 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.3 | 0.8 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.3 | 0.8 | GO:0044838 | cell quiescence(GO:0044838) |
0.3 | 0.8 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.3 | 0.3 | GO:0060290 | transdifferentiation(GO:0060290) |
0.3 | 6.4 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.3 | 1.1 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.3 | 2.9 | GO:0051236 | establishment of RNA localization(GO:0051236) |
0.3 | 1.3 | GO:0046688 | response to copper ion(GO:0046688) |
0.3 | 1.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.3 | 0.3 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.3 | 2.6 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.3 | 2.4 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.3 | 1.6 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.3 | 6.8 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.3 | 0.3 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.3 | 0.5 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.3 | 3.6 | GO:0019835 | cytolysis(GO:0019835) |
0.3 | 0.3 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.3 | 3.4 | GO:0006491 | N-glycan processing(GO:0006491) |
0.3 | 0.3 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.3 | 7.7 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.3 | 0.5 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.3 | 0.3 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.3 | 0.3 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.3 | 15.3 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.3 | 0.8 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.3 | 3.3 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
0.3 | 0.5 | GO:0042628 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.3 | 0.5 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.3 | 0.8 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.3 | 0.5 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.3 | 1.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.3 | 1.8 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.3 | 1.0 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.3 | 0.3 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 1.0 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.2 | 0.5 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
0.2 | 1.5 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) |
0.2 | 0.2 | GO:0032823 | regulation of natural killer cell differentiation(GO:0032823) |
0.2 | 0.7 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.2 | 4.2 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.2 | 0.2 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.2 | 3.4 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.2 | 2.4 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
0.2 | 0.5 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.2 | 0.7 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.2 | 1.7 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.2 | 0.5 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.2 | 2.7 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.2 | 1.7 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.2 | 6.3 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.2 | 0.5 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
0.2 | 3.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 4.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 0.5 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 0.7 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.2 | 1.0 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.2 | 1.2 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) |
0.2 | 2.4 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.2 | 0.5 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.2 | 0.2 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.2 | 0.9 | GO:0000279 | M phase(GO:0000279) meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.2 | 0.5 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.2 | 0.2 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.2 | 0.5 | GO:0046677 | response to antibiotic(GO:0046677) |
0.2 | 0.9 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.2 | 0.7 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 0.7 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 2.3 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.2 | 1.9 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.2 | 0.5 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 0.9 | GO:1903311 | regulation of mRNA metabolic process(GO:1903311) |
0.2 | 6.2 | GO:0009060 | aerobic respiration(GO:0009060) |
0.2 | 0.9 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
0.2 | 0.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 0.5 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.2 | 0.7 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.2 | 0.5 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 0.9 | GO:0010324 | membrane invagination(GO:0010324) |
0.2 | 0.2 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.2 | 0.7 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 0.9 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 0.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 0.5 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.2 | 0.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 0.7 | GO:0043297 | apical junction assembly(GO:0043297) |
0.2 | 0.4 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.2 | 0.2 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.2 | 0.7 | GO:0000032 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.2 | 4.0 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.2 | 0.4 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.2 | 0.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 4.4 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.2 | 1.1 | GO:0051304 | chromosome separation(GO:0051304) |
0.2 | 0.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 4.9 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.2 | 0.7 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.2 | 0.7 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 0.7 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.2 | 0.2 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.2 | 0.7 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.2 | 0.2 | GO:0060416 | response to growth hormone(GO:0060416) |
0.2 | 1.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 1.9 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.2 | 0.4 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.2 | 0.2 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.2 | 1.3 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.6 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.2 | 1.1 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.2 | 1.5 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.2 | 0.4 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.2 | 0.2 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.2 | 0.2 | GO:2000191 | regulation of fatty acid transport(GO:2000191) |
0.2 | 0.2 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.2 | 3.2 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.2 | 0.4 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.2 | 0.2 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.2 | 0.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 1.5 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.2 | 11.2 | GO:0006457 | protein folding(GO:0006457) |
0.2 | 1.3 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 1.3 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.2 | 0.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.2 | 0.2 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.2 | 0.8 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 5.5 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.2 | 0.6 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.2 | 1.5 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 1.3 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.2 | 1.9 | GO:1903052 | positive regulation of proteolysis involved in cellular protein catabolic process(GO:1903052) |
0.2 | 2.1 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.2 | 0.8 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.2 | 1.2 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.2 | 0.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 2.5 | GO:0098534 | centriole assembly(GO:0098534) |
0.2 | 0.2 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
0.2 | 0.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 5.1 | GO:0009988 | cell-cell recognition(GO:0009988) sperm-egg recognition(GO:0035036) |
0.2 | 0.6 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.2 | 0.4 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 0.2 | GO:0021571 | rhombomere 4 development(GO:0021570) rhombomere 5 development(GO:0021571) |
0.2 | 0.2 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.2 | 0.6 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.2 | 0.4 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.2 | 5.1 | GO:0031929 | TOR signaling(GO:0031929) |
0.2 | 0.4 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.2 | 7.9 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.2 | 4.8 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.2 | 0.6 | GO:1901032 | negative regulation of response to reactive oxygen species(GO:1901032) |
0.2 | 1.4 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.2 | 1.6 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.2 | 0.2 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.2 | 0.8 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.2 | 1.0 | GO:0072698 | protein localization to microtubule cytoskeleton(GO:0072698) |
0.2 | 0.6 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.2 | 3.0 | GO:0030261 | chromosome condensation(GO:0030261) |
0.2 | 0.6 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.2 | 8.7 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.2 | 0.4 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.2 | 0.4 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 0.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 0.6 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 5.1 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.2 | 0.2 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.2 | 1.6 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.2 | 5.8 | GO:0001824 | blastocyst development(GO:0001824) |
0.2 | 0.2 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.2 | 1.4 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 0.2 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.2 | 0.2 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.2 | 1.0 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.2 | 0.6 | GO:0015816 | glycine transport(GO:0015816) |
0.2 | 0.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 0.6 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.2 | 0.4 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.2 | 0.2 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.2 | 0.2 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.2 | 0.6 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 0.2 | GO:1903053 | regulation of extracellular matrix organization(GO:1903053) |
0.2 | 0.2 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.2 | 1.7 | GO:0070542 | response to fatty acid(GO:0070542) |
0.2 | 0.4 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.2 | 0.2 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.2 | 1.5 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.2 | 1.1 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 0.2 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.2 | 0.4 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.2 | 0.7 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.2 | 0.4 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.2 | 0.9 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.2 | 0.6 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.2 | 2.4 | GO:0009268 | response to pH(GO:0009268) |
0.2 | 0.4 | GO:0015744 | succinate transport(GO:0015744) |
0.2 | 1.8 | GO:0045214 | sarcomere organization(GO:0045214) |
0.2 | 1.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 0.7 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.2 | 0.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.9 | GO:1904970 | brush border assembly(GO:1904970) |
0.2 | 0.2 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.2 | 0.2 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.2 | 0.2 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.2 | 0.9 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 0.2 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
0.2 | 0.5 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.5 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.2 | 0.2 | GO:2000822 | regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
0.2 | 0.5 | GO:0060005 | vestibular reflex(GO:0060005) |
0.2 | 0.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 1.9 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.2 | 0.4 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.2 | 0.4 | GO:0050832 | defense response to fungus(GO:0050832) |
0.2 | 0.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.2 | 1.9 | GO:0007588 | excretion(GO:0007588) |
0.2 | 1.7 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.2 | 0.2 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 0.9 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.2 | 0.2 | GO:0008355 | olfactory learning(GO:0008355) |
0.2 | 0.9 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 0.9 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.2 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.2 | 1.4 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.2 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 0.5 | GO:0042516 | regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
0.2 | 0.3 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.2 | 2.2 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.2 | 0.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 0.5 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.2 | 0.3 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.2 | 0.3 | GO:0050942 | positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
0.2 | 0.3 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.2 | 0.8 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.2 | 0.2 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.2 | 1.7 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.2 | 0.5 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.2 | 3.7 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.2 | 0.7 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.2 | 0.2 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.2 | 0.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.5 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.2 | 0.2 | GO:2001274 | immunoglobulin biosynthetic process(GO:0002378) negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.2 | 0.3 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.2 | 0.7 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.2 | 0.3 | GO:0015669 | gas transport(GO:0015669) |
0.2 | 0.3 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.2 | 0.2 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.2 | 0.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 0.8 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.2 | 4.0 | GO:0098840 | intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
0.2 | 0.2 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.2 | 1.0 | GO:0006096 | glycolytic process(GO:0006096) |
0.2 | 0.5 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.2 | 0.5 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.2 | 0.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 1.6 | GO:0006284 | base-excision repair(GO:0006284) |
0.2 | 0.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.2 | 0.3 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.2 | 0.5 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.2 | 1.1 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.2 | 0.8 | GO:0043489 | RNA stabilization(GO:0043489) |
0.2 | 0.2 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.2 | 0.2 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.2 | 0.2 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.2 | 0.3 | GO:0072224 | metanephric glomerulus development(GO:0072224) |
0.2 | 1.2 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.2 | 0.8 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.2 | 11.9 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.1 | 4.0 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 1.2 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 3.0 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 5.4 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 0.1 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.1 | 15.6 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.4 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.1 | 0.1 | GO:0048021 | regulation of secondary metabolic process(GO:0043455) regulation of melanin biosynthetic process(GO:0048021) negative regulation of melanin biosynthetic process(GO:0048022) regulation of secondary metabolite biosynthetic process(GO:1900376) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.1 | 0.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.3 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.1 | 0.6 | GO:0048757 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.1 | 0.3 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.1 | 0.6 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.1 | 0.6 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.1 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.1 | 0.4 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 2.0 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.7 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 0.3 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 1.4 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 1.0 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 1.0 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.1 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.1 | 0.7 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.7 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.1 | 0.6 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 0.3 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 3.3 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.1 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.1 | 1.0 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.1 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.1 | 0.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 1.2 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.1 | 0.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.1 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.1 | 1.2 | GO:0007492 | endoderm development(GO:0007492) |
0.1 | 0.1 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.1 | 0.3 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.5 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 0.1 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 0.1 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) |
0.1 | 0.3 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 0.3 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 1.4 | GO:0071466 | cellular response to xenobiotic stimulus(GO:0071466) |
0.1 | 0.1 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.1 | 0.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.1 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 0.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.3 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 6.3 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.1 | 0.1 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.4 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.1 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
0.1 | 0.1 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.1 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.1 | 0.8 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.1 | 0.1 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.1 | 1.4 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 1.8 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
0.1 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.1 | 4.4 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.1 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.1 | 1.6 | GO:0042255 | ribosome assembly(GO:0042255) |
0.1 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.6 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 1.6 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.2 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.1 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.3 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.2 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.2 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.1 | 2.2 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.1 | 0.3 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
0.1 | 1.4 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.1 | 2.2 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 1.4 | GO:0010634 | positive regulation of epithelial cell migration(GO:0010634) |
0.1 | 1.0 | GO:0051972 | regulation of telomerase activity(GO:0051972) |
0.1 | 0.9 | GO:0072662 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 0.6 | GO:0007129 | synapsis(GO:0007129) |
0.1 | 0.2 | GO:0060711 | labyrinthine layer development(GO:0060711) |
0.1 | 0.8 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.3 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.1 | 0.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 0.1 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) |
0.1 | 1.4 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.3 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.2 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 1.8 | GO:0036503 | ERAD pathway(GO:0036503) |
0.1 | 0.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.7 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.4 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.5 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.1 | 0.2 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.1 | GO:0072182 | regulation of nephron tubule epithelial cell differentiation(GO:0072182) |
0.1 | 1.1 | GO:0030574 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
0.1 | 0.5 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.2 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 0.3 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.5 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 0.3 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.1 | 1.2 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.1 | 0.1 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.1 | GO:2000050 | regulation of non-canonical Wnt signaling pathway(GO:2000050) |
0.1 | 0.1 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.1 | 1.2 | GO:0010171 | body morphogenesis(GO:0010171) |
0.1 | 0.3 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.1 | 0.1 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.1 | 1.3 | GO:0046330 | positive regulation of JNK cascade(GO:0046330) |
0.1 | 0.4 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
0.1 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.8 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 4.9 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.1 | 0.1 | GO:1904181 | positive regulation of membrane depolarization(GO:1904181) |
0.1 | 0.2 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.1 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 4.4 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.1 | 0.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.4 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.1 | 0.1 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 2.3 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.3 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.1 | GO:1905039 | organic acid transmembrane transport(GO:1903825) carboxylic acid transmembrane transport(GO:1905039) |
0.1 | 0.4 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.1 | 0.3 | GO:0042542 | response to hydrogen peroxide(GO:0042542) |
0.1 | 0.2 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.1 | 0.4 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.1 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.1 | 0.3 | GO:0032874 | positive regulation of stress-activated MAPK cascade(GO:0032874) positive regulation of stress-activated protein kinase signaling cascade(GO:0070304) |
0.1 | 0.1 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.1 | 0.4 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.4 | GO:0097028 | dendritic cell differentiation(GO:0097028) |
0.1 | 0.2 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.4 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.7 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 0.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.1 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.1 | 0.1 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.3 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.1 | 1.7 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.3 | GO:0032891 | negative regulation of organic acid transport(GO:0032891) negative regulation of amino acid transport(GO:0051956) |
0.1 | 0.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.1 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.4 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.2 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.1 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.1 | 0.1 | GO:0002673 | regulation of acute inflammatory response(GO:0002673) |
0.1 | 0.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.2 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.1 | 0.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.1 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.1 | 0.1 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.1 | 0.1 | GO:2001026 | regulation of endothelial cell chemotaxis(GO:2001026) |
0.1 | 0.2 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 0.1 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 0.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 0.2 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.9 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.2 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.1 | 0.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 0.5 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.4 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.1 | 0.6 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 0.2 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.1 | 0.6 | GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
0.1 | 0.1 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 0.1 | GO:0033628 | regulation of cell adhesion mediated by integrin(GO:0033628) |
0.1 | 0.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 0.1 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.1 | 0.4 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.1 | GO:0033058 | directional locomotion(GO:0033058) |
0.1 | 0.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.1 | GO:0016052 | carbohydrate catabolic process(GO:0016052) |
0.1 | 0.1 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.1 | 0.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.1 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 0.1 | GO:0010984 | regulation of lipoprotein particle clearance(GO:0010984) |
0.1 | 0.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.6 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.4 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.1 | 0.1 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.1 | 0.1 | GO:0001952 | regulation of cell-matrix adhesion(GO:0001952) |
0.1 | 0.1 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.1 | 11.4 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 1.4 | GO:0006665 | sphingolipid metabolic process(GO:0006665) |
0.1 | 1.5 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.1 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.1 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 0.7 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.1 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.1 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.1 | 0.4 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.1 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.3 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.8 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.1 | 0.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.4 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.2 | GO:0050922 | negative regulation of chemotaxis(GO:0050922) |
0.1 | 0.6 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.2 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.1 | 0.2 | GO:1902930 | regulation of alcohol biosynthetic process(GO:1902930) |
0.1 | 0.3 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.2 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.1 | 0.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.1 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.1 | 0.1 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 0.1 | GO:0070741 | response to interleukin-6(GO:0070741) |
0.1 | 0.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.1 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.1 | 0.1 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.1 | 0.1 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.1 | 0.6 | GO:0006213 | pyrimidine nucleoside metabolic process(GO:0006213) |
0.0 | 0.0 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.0 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.6 | GO:0043149 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.0 | 0.0 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.0 | 0.1 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
0.0 | 0.0 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.1 | GO:0050810 | regulation of steroid biosynthetic process(GO:0050810) |
0.0 | 0.7 | GO:1905037 | autophagosome organization(GO:1905037) |
0.0 | 1.3 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.0 | 0.0 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.0 | 47.6 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.0 | 4.4 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.4 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.0 | 0.0 | GO:0046467 | membrane lipid biosynthetic process(GO:0046467) |
0.0 | 0.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.0 | 0.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.0 | 0.0 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.0 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.1 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.0 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.0 | 0.0 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.0 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.0 | 0.0 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) convergent extension involved in gastrulation(GO:0060027) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.0 | 0.2 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.1 | GO:0035090 | maintenance of cell polarity(GO:0030011) maintenance of apical/basal cell polarity(GO:0035090) |
0.0 | 0.0 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.0 | 0.5 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.0 | 0.1 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) |
0.0 | 0.0 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.0 | 0.2 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.0 | 0.0 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.0 | 0.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.0 | 0.0 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.0 | 0.1 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.0 | 0.0 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.0 | 0.1 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.7 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.0 | GO:0042107 | cytokine metabolic process(GO:0042107) |
0.0 | 0.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.0 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 0.0 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 0.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 3.5 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.0 | 0.0 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.0 | 0.0 | GO:0033627 | cell adhesion mediated by integrin(GO:0033627) |
0.0 | 0.0 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.0 | 0.0 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.0 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.0 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.0 | 0.3 | GO:0001890 | placenta development(GO:0001890) |
0.0 | 0.0 | GO:0061055 | myotome development(GO:0061055) |
0.0 | 0.0 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.0 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.0 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.1 | GO:0042159 | protein depalmitoylation(GO:0002084) lipoprotein catabolic process(GO:0042159) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.0 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.0 | 0.0 | GO:0010559 | regulation of glycoprotein biosynthetic process(GO:0010559) |
0.0 | 0.0 | GO:0070417 | cellular response to cold(GO:0070417) |
0.0 | 3.8 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.0 | 0.0 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.0 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.0 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.0 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.0 | 0.0 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.0 | 0.0 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 13.5 | GO:0097413 | Lewy body(GO:0097413) |
4.1 | 4.1 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
3.2 | 22.1 | GO:0043219 | lateral loop(GO:0043219) |
3.1 | 9.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
2.8 | 14.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
2.6 | 7.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
2.3 | 11.6 | GO:0030870 | Mre11 complex(GO:0030870) |
2.3 | 9.1 | GO:0098536 | deuterosome(GO:0098536) |
2.2 | 11.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
2.0 | 9.9 | GO:0001651 | dense fibrillar component(GO:0001651) |
2.0 | 7.9 | GO:0030127 | COPII vesicle coat(GO:0030127) |
1.9 | 9.5 | GO:0005638 | lamin filament(GO:0005638) |
1.9 | 13.1 | GO:0042382 | paraspeckles(GO:0042382) |
1.8 | 5.5 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.8 | 9.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.8 | 5.4 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
1.7 | 5.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.7 | 5.2 | GO:0016939 | kinesin II complex(GO:0016939) |
1.7 | 5.1 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.7 | 8.3 | GO:0005828 | kinetochore microtubule(GO:0005828) |
1.6 | 4.8 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.6 | 6.3 | GO:0071203 | WASH complex(GO:0071203) |
1.5 | 35.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
1.5 | 11.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
1.5 | 4.4 | GO:0005745 | m-AAA complex(GO:0005745) |
1.4 | 15.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.4 | 9.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.3 | 6.7 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
1.3 | 10.7 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
1.3 | 20.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
1.3 | 4.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.3 | 3.9 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
1.2 | 3.7 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.2 | 9.3 | GO:0044232 | organelle membrane contact site(GO:0044232) |
1.2 | 5.8 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
1.2 | 8.1 | GO:0032982 | myosin filament(GO:0032982) |
1.1 | 5.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.1 | 3.4 | GO:0097443 | sorting endosome(GO:0097443) |
1.1 | 3.4 | GO:0005955 | calcineurin complex(GO:0005955) |
1.1 | 2.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
1.1 | 18.9 | GO:0016460 | myosin II complex(GO:0016460) |
1.1 | 1.1 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
1.1 | 3.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
1.1 | 14.9 | GO:0000974 | Prp19 complex(GO:0000974) |
1.1 | 11.7 | GO:0042575 | DNA polymerase complex(GO:0042575) |
1.1 | 5.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.0 | 8.3 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
1.0 | 6.1 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
1.0 | 2.0 | GO:0016342 | catenin complex(GO:0016342) |
1.0 | 4.0 | GO:0071953 | elastic fiber(GO:0071953) |
1.0 | 3.0 | GO:0005712 | chiasma(GO:0005712) |
1.0 | 2.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.0 | 12.0 | GO:0042627 | chylomicron(GO:0042627) |
1.0 | 4.0 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.0 | 2.0 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.0 | 20.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
1.0 | 1.9 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.0 | 1.0 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.9 | 2.8 | GO:0001650 | fibrillar center(GO:0001650) |
0.9 | 2.8 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.9 | 5.6 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.9 | 3.7 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.9 | 3.7 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.9 | 0.9 | GO:0032994 | protein-lipid complex(GO:0032994) plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.9 | 8.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.9 | 7.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.9 | 2.7 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.9 | 1.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.9 | 8.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.8 | 3.4 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.8 | 13.5 | GO:0000145 | exocyst(GO:0000145) |
0.8 | 3.4 | GO:0005642 | annulate lamellae(GO:0005642) |
0.8 | 3.4 | GO:0072487 | MSL complex(GO:0072487) |
0.8 | 0.8 | GO:1990423 | RZZ complex(GO:1990423) |
0.8 | 2.4 | GO:0032437 | cuticular plate(GO:0032437) |
0.8 | 4.9 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.8 | 2.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.8 | 2.4 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.8 | 4.0 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.8 | 1.6 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.8 | 2.4 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.8 | 2.4 | GO:0061574 | ASAP complex(GO:0061574) |
0.8 | 7.9 | GO:0032797 | SMN complex(GO:0032797) |
0.8 | 1.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.8 | 0.8 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.8 | 3.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.8 | 2.3 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.8 | 3.1 | GO:0030478 | actin cap(GO:0030478) |
0.8 | 34.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.8 | 2.3 | GO:0000811 | GINS complex(GO:0000811) |
0.8 | 5.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.8 | 7.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.8 | 2.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.8 | 7.5 | GO:0031932 | TORC2 complex(GO:0031932) |
0.8 | 9.0 | GO:0031528 | microvillus membrane(GO:0031528) |
0.8 | 45.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.7 | 3.0 | GO:0097452 | GAIT complex(GO:0097452) |
0.7 | 70.2 | GO:0072562 | blood microparticle(GO:0072562) |
0.7 | 4.5 | GO:0071986 | Ragulator complex(GO:0071986) |
0.7 | 1.5 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.7 | 1.5 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.7 | 2.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.7 | 5.7 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.7 | 6.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.7 | 7.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.7 | 2.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.7 | 2.1 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.7 | 2.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.7 | 30.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.7 | 1.4 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.7 | 2.8 | GO:0000805 | X chromosome(GO:0000805) |
0.7 | 2.8 | GO:0016589 | NURF complex(GO:0016589) |
0.7 | 34.3 | GO:0005811 | lipid particle(GO:0005811) |
0.7 | 12.7 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.7 | 2.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.7 | 5.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.7 | 5.2 | GO:0070938 | contractile ring(GO:0070938) |
0.6 | 3.9 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.6 | 7.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.6 | 4.5 | GO:0032426 | stereocilium tip(GO:0032426) |
0.6 | 0.6 | GO:0032010 | phagolysosome(GO:0032010) |
0.6 | 5.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.6 | 7.7 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.6 | 3.2 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.6 | 5.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.6 | 13.4 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.6 | 21.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.6 | 3.8 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.6 | 2.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.6 | 11.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.6 | 21.3 | GO:0005776 | autophagosome(GO:0005776) |
0.6 | 1.9 | GO:0055037 | recycling endosome(GO:0055037) |
0.6 | 28.7 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.6 | 1.9 | GO:0000322 | storage vacuole(GO:0000322) |
0.6 | 2.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.6 | 7.4 | GO:0002102 | podosome(GO:0002102) |
0.6 | 1.2 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.6 | 7.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.6 | 1.2 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.6 | 2.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.6 | 2.4 | GO:0000938 | GARP complex(GO:0000938) |
0.6 | 10.2 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.6 | 35.1 | GO:0016363 | nuclear matrix(GO:0016363) |
0.6 | 1.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.6 | 4.2 | GO:0043203 | axon hillock(GO:0043203) |
0.6 | 10.0 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.6 | 2.9 | GO:0042629 | mast cell granule(GO:0042629) |
0.6 | 2.9 | GO:0072687 | meiotic spindle(GO:0072687) |
0.6 | 8.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.6 | 12.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.6 | 1.7 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.6 | 1.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.6 | 4.0 | GO:0042641 | actomyosin(GO:0042641) |
0.6 | 2.3 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.6 | 1.7 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.6 | 1.7 | GO:0000242 | pericentriolar material(GO:0000242) |
0.6 | 2.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.6 | 2.8 | GO:0031252 | cell leading edge(GO:0031252) |
0.6 | 1.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.6 | 2.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.6 | 8.9 | GO:0005682 | U5 snRNP(GO:0005682) |
0.6 | 0.6 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.6 | 21.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.6 | 4.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.5 | 3.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.5 | 1.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.5 | 2.7 | GO:0030914 | STAGA complex(GO:0030914) |
0.5 | 3.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.5 | 4.3 | GO:0000803 | sex chromosome(GO:0000803) |
0.5 | 7.0 | GO:0036038 | MKS complex(GO:0036038) |
0.5 | 4.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.5 | 0.5 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.5 | 1.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.5 | 4.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.5 | 5.9 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.5 | 1.6 | GO:0030891 | VCB complex(GO:0030891) |
0.5 | 2.1 | GO:0001652 | granular component(GO:0001652) |
0.5 | 5.9 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.5 | 1.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.5 | 2.7 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.5 | 2.7 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.5 | 1.1 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.5 | 2.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.5 | 4.7 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.5 | 1.6 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.5 | 6.8 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.5 | 3.7 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.5 | 0.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.5 | 0.5 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.5 | 17.2 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.5 | 0.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.5 | 4.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.5 | 1.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.5 | 1.5 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.5 | 3.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.5 | 1.5 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.5 | 0.5 | GO:0045180 | basal cortex(GO:0045180) |
0.5 | 2.0 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.5 | 1.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.5 | 39.4 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.5 | 2.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.5 | 1.0 | GO:0030120 | vesicle coat(GO:0030120) |
0.5 | 0.5 | GO:0031045 | dense core granule(GO:0031045) |
0.5 | 2.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.5 | 4.5 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.5 | 0.5 | GO:0097427 | microtubule bundle(GO:0097427) |
0.5 | 3.9 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.5 | 1.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.5 | 9.6 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.5 | 1.4 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.5 | 4.7 | GO:0071010 | prespliceosome(GO:0071010) |
0.5 | 6.2 | GO:0043196 | varicosity(GO:0043196) |
0.5 | 4.7 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.5 | 4.2 | GO:0042581 | specific granule(GO:0042581) |
0.5 | 3.8 | GO:0005861 | troponin complex(GO:0005861) |
0.5 | 38.4 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.5 | 4.7 | GO:0031941 | filamentous actin(GO:0031941) |
0.5 | 4.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.5 | 0.9 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.5 | 11.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.5 | 3.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.5 | 1.4 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.5 | 43.3 | GO:0005903 | brush border(GO:0005903) |
0.5 | 4.1 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.5 | 0.9 | GO:0005683 | U7 snRNP(GO:0005683) |
0.5 | 4.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.5 | 3.2 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.5 | 3.6 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.4 | 5.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.4 | 3.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.4 | 4.9 | GO:0005771 | multivesicular body(GO:0005771) |
0.4 | 1.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.4 | 1.3 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.4 | 4.7 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.4 | 0.4 | GO:0045178 | basal part of cell(GO:0045178) |
0.4 | 29.9 | GO:0005581 | collagen trimer(GO:0005581) |
0.4 | 14.5 | GO:0005795 | Golgi stack(GO:0005795) |
0.4 | 1.7 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.4 | 1.3 | GO:0048179 | activin receptor complex(GO:0048179) |
0.4 | 3.0 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.4 | 0.8 | GO:0005579 | membrane attack complex(GO:0005579) |
0.4 | 1.3 | GO:0031415 | NatA complex(GO:0031415) |
0.4 | 3.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.4 | 2.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.4 | 0.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.4 | 5.0 | GO:1904949 | ATPase complex(GO:1904949) |
0.4 | 1.7 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.4 | 6.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.4 | 2.0 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.4 | 0.4 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.4 | 4.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.4 | 4.8 | GO:0033391 | chromatoid body(GO:0033391) |
0.4 | 96.3 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.4 | 7.9 | GO:0005901 | caveola(GO:0005901) |
0.4 | 2.0 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.4 | 1.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.4 | 0.8 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.4 | 5.5 | GO:0031519 | PcG protein complex(GO:0031519) |
0.4 | 1.6 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.4 | 7.4 | GO:0090544 | BAF-type complex(GO:0090544) |
0.4 | 3.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.4 | 24.0 | GO:0000922 | spindle pole(GO:0000922) |
0.4 | 4.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.4 | 2.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.4 | 6.4 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.4 | 7.1 | GO:0005876 | spindle microtubule(GO:0005876) |
0.4 | 2.6 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.4 | 0.4 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.4 | 1.1 | GO:1990130 | Iml1 complex(GO:1990130) |
0.4 | 1.5 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.4 | 2.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.4 | 1.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.4 | 0.4 | GO:0005652 | nuclear lamina(GO:0005652) |
0.4 | 0.4 | GO:0031523 | Myb complex(GO:0031523) |
0.4 | 2.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.4 | 1.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.4 | 0.4 | GO:0071437 | invadopodium(GO:0071437) |
0.4 | 5.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.4 | 0.4 | GO:0055087 | Ski complex(GO:0055087) |
0.4 | 0.7 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.4 | 2.5 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.3 | 1.0 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.3 | 1.0 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 0.7 | GO:0097542 | ciliary tip(GO:0097542) |
0.3 | 18.0 | GO:0005770 | late endosome(GO:0005770) |
0.3 | 5.2 | GO:0031672 | A band(GO:0031672) |
0.3 | 2.1 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.3 | 8.9 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 1.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.3 | 1.0 | GO:0035838 | growing cell tip(GO:0035838) |
0.3 | 0.3 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.3 | 5.4 | GO:0032040 | small-subunit processome(GO:0032040) |
0.3 | 13.4 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 0.7 | GO:1990923 | PET complex(GO:1990923) |
0.3 | 2.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 1.3 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.3 | 2.0 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.3 | 3.6 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 7.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.3 | 0.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 11.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.3 | 0.6 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.3 | 7.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.3 | 0.6 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.3 | 3.4 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.3 | 0.9 | GO:0031417 | NatC complex(GO:0031417) |
0.3 | 0.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.3 | 0.9 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 7.6 | GO:0032587 | ruffle membrane(GO:0032587) |
0.3 | 0.6 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.3 | 5.7 | GO:0097228 | sperm principal piece(GO:0097228) |
0.3 | 0.6 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.3 | 2.7 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.3 | 1.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.3 | 2.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.3 | 3.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.3 | 1.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.3 | 1.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 22.6 | GO:0000139 | Golgi membrane(GO:0000139) |
0.3 | 0.9 | GO:0097546 | ciliary base(GO:0097546) |
0.3 | 2.6 | GO:0046930 | pore complex(GO:0046930) |
0.3 | 1.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.3 | 0.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 3.2 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.3 | 0.9 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.3 | 5.5 | GO:0010008 | endosome membrane(GO:0010008) |
0.3 | 0.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.3 | 0.8 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.3 | 2.0 | GO:0016272 | prefoldin complex(GO:0016272) |
0.3 | 4.8 | GO:0005844 | polysome(GO:0005844) |
0.3 | 2.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 1.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.3 | 6.6 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.3 | 0.8 | GO:0097255 | R2TP complex(GO:0097255) |
0.3 | 0.8 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.3 | 2.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.3 | 1.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.3 | 5.7 | GO:0031901 | early endosome membrane(GO:0031901) |
0.3 | 6.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.3 | 22.0 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.3 | 8.8 | GO:0043292 | contractile fiber(GO:0043292) |
0.3 | 1.0 | GO:0089701 | U2AF(GO:0089701) |
0.3 | 0.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.3 | 1.3 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.3 | 12.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.3 | 12.0 | GO:0016605 | PML body(GO:0016605) |
0.3 | 4.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 26.7 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.3 | 0.5 | GO:0043198 | dendritic shaft(GO:0043198) |
0.3 | 50.8 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.3 | 2.0 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.3 | 0.5 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.3 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.3 | 0.3 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.2 | 0.5 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 0.7 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
0.2 | 0.7 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 1.0 | GO:0097386 | glial cell projection(GO:0097386) |
0.2 | 9.7 | GO:0016607 | nuclear speck(GO:0016607) |
0.2 | 2.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 8.9 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 0.5 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.2 | 224.1 | GO:0005829 | cytosol(GO:0005829) |
0.2 | 1.2 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 37.8 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 1.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 2.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 0.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.2 | 14.1 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.2 | 11.4 | GO:0005938 | cell cortex(GO:0005938) |
0.2 | 180.6 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.2 | 0.9 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.2 | 2.7 | GO:0043205 | fibril(GO:0043205) |
0.2 | 2.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 1.7 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.2 | 2.1 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.2 | 12.9 | GO:0000793 | condensed chromosome(GO:0000793) |
0.2 | 2.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 0.8 | GO:0030897 | HOPS complex(GO:0030897) |
0.2 | 2.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 2.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 0.6 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 22.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 10.4 | GO:0005882 | intermediate filament(GO:0005882) |
0.2 | 1.5 | GO:0060170 | ciliary membrane(GO:0060170) |
0.2 | 0.6 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 1.3 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.2 | 0.4 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 3.4 | GO:0005884 | actin filament(GO:0005884) |
0.2 | 41.0 | GO:0044429 | mitochondrial part(GO:0044429) |
0.2 | 0.3 | GO:0005914 | spot adherens junction(GO:0005914) |
0.2 | 193.4 | GO:0070062 | extracellular exosome(GO:0070062) |
0.2 | 4.5 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 134.6 | GO:0005654 | nucleoplasm(GO:0005654) |
0.2 | 2.5 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 10.9 | GO:1990234 | transferase complex(GO:1990234) |
0.2 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 1.9 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.4 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 4.9 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 1.4 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 2.2 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 4.6 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 3.8 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 46.0 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.1 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 2.9 | GO:0044420 | extracellular matrix component(GO:0044420) |
0.1 | 4.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.2 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 2.9 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 0.2 | GO:0044437 | vacuolar part(GO:0044437) |
0.1 | 0.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 3.9 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 0.9 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 12.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.3 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 0.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 3.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.7 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 2.0 | GO:0044309 | neuron spine(GO:0044309) |
0.1 | 0.2 | GO:0030141 | secretory granule(GO:0030141) |
0.1 | 0.2 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.1 | 0.4 | GO:0030286 | dynein complex(GO:0030286) |
0.1 | 0.3 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.2 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.7 | GO:0009986 | cell surface(GO:0009986) |
0.1 | 0.3 | GO:0000428 | DNA-directed RNA polymerase complex(GO:0000428) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
0.1 | 2.9 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 0.2 | GO:0034399 | nuclear periphery(GO:0034399) |
0.0 | 0.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 1.0 | GO:1902494 | catalytic complex(GO:1902494) |
0.0 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.4 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.0 | 39.5 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 131.6 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 60.8 | GO:0005622 | intracellular(GO:0005622) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 15.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
5.2 | 15.6 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
5.0 | 14.9 | GO:0004771 | sterol esterase activity(GO:0004771) |
4.6 | 13.7 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
4.2 | 12.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
3.9 | 15.7 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
3.5 | 10.6 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
3.5 | 10.5 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
3.2 | 25.5 | GO:0008430 | selenium binding(GO:0008430) |
3.2 | 9.5 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
3.2 | 9.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
2.9 | 8.6 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
2.8 | 11.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
2.6 | 28.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
2.6 | 7.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
2.5 | 5.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
2.5 | 7.5 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
2.5 | 14.8 | GO:0016936 | galactoside binding(GO:0016936) |
2.4 | 7.2 | GO:0055100 | adiponectin binding(GO:0055100) |
2.4 | 9.5 | GO:0031720 | haptoglobin binding(GO:0031720) |
2.4 | 9.5 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
2.3 | 6.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
2.2 | 6.7 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
2.2 | 6.6 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
2.1 | 19.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
2.1 | 2.1 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
2.1 | 6.2 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
2.1 | 6.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
2.0 | 2.0 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
2.0 | 5.9 | GO:0004064 | arylesterase activity(GO:0004064) |
1.9 | 5.8 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.9 | 5.8 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.9 | 15.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
1.9 | 15.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.9 | 13.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.9 | 9.5 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
1.9 | 9.4 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
1.9 | 9.4 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
1.8 | 5.5 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
1.8 | 5.5 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
1.8 | 5.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.8 | 9.0 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
1.8 | 7.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
1.8 | 1.8 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
1.8 | 5.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.8 | 10.6 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.7 | 10.4 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
1.7 | 5.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.7 | 30.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
1.7 | 6.7 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.7 | 8.4 | GO:0005499 | vitamin D binding(GO:0005499) |
1.7 | 1.7 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
1.6 | 6.4 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
1.6 | 8.0 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
1.6 | 11.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
1.6 | 1.6 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
1.6 | 9.5 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
1.6 | 3.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
1.6 | 4.7 | GO:1990188 | euchromatin binding(GO:1990188) |
1.6 | 4.7 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
1.5 | 7.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.5 | 10.6 | GO:0019966 | interleukin-1 binding(GO:0019966) |
1.5 | 4.5 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.5 | 15.1 | GO:0005536 | glucose binding(GO:0005536) |
1.5 | 37.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
1.5 | 3.0 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
1.5 | 4.5 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.5 | 7.4 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
1.5 | 13.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.5 | 5.9 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.5 | 4.4 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
1.5 | 5.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.5 | 5.8 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
1.5 | 11.6 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
1.4 | 5.8 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.4 | 7.2 | GO:0000405 | bubble DNA binding(GO:0000405) |
1.4 | 4.2 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
1.4 | 2.8 | GO:1990715 | mRNA CDS binding(GO:1990715) |
1.4 | 8.3 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
1.4 | 2.8 | GO:0070538 | oleic acid binding(GO:0070538) |
1.4 | 4.1 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
1.4 | 9.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.4 | 5.4 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
1.3 | 9.4 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
1.3 | 4.0 | GO:0008142 | oxysterol binding(GO:0008142) |
1.3 | 5.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
1.3 | 10.6 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
1.3 | 5.3 | GO:0009374 | biotin binding(GO:0009374) |
1.3 | 3.9 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.3 | 2.6 | GO:0019959 | interleukin-8 binding(GO:0019959) |
1.3 | 5.1 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
1.3 | 2.5 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
1.3 | 5.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.2 | 5.0 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.2 | 8.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.2 | 3.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.2 | 13.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
1.2 | 2.5 | GO:0016531 | copper chaperone activity(GO:0016531) superoxide dismutase copper chaperone activity(GO:0016532) |
1.2 | 4.9 | GO:0043515 | kinetochore binding(GO:0043515) |
1.2 | 6.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.2 | 6.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
1.2 | 6.0 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
1.2 | 17.9 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
1.2 | 8.1 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) DNA polymerase activity(GO:0034061) |
1.2 | 5.8 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.2 | 4.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
1.1 | 3.4 | GO:0030621 | U4 snRNA binding(GO:0030621) |
1.1 | 3.4 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
1.1 | 10.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.1 | 9.1 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
1.1 | 10.2 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
1.1 | 12.4 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
1.1 | 3.4 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.1 | 3.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.1 | 2.2 | GO:0050692 | DBD domain binding(GO:0050692) |
1.1 | 3.3 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
1.1 | 12.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.1 | 5.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
1.1 | 4.4 | GO:0015232 | heme transporter activity(GO:0015232) |
1.1 | 36.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
1.1 | 4.4 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.1 | 3.3 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
1.1 | 3.3 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
1.1 | 7.6 | GO:0016803 | ether hydrolase activity(GO:0016803) |
1.1 | 3.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
1.1 | 7.5 | GO:0018641 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
1.1 | 7.5 | GO:0048406 | nerve growth factor binding(GO:0048406) |
1.1 | 7.4 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
1.1 | 3.2 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
1.1 | 1.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
1.0 | 3.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.0 | 6.3 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
1.0 | 26.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
1.0 | 3.1 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
1.0 | 6.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
1.0 | 6.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
1.0 | 3.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
1.0 | 4.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.0 | 4.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.0 | 3.0 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.0 | 1.0 | GO:0042887 | amide transmembrane transporter activity(GO:0042887) |
1.0 | 12.2 | GO:0005542 | folic acid binding(GO:0005542) |
1.0 | 4.0 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
1.0 | 4.0 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
1.0 | 5.0 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.0 | 5.0 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
1.0 | 11.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
1.0 | 1.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.0 | 3.0 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
1.0 | 3.0 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
1.0 | 10.9 | GO:0001846 | opsonin binding(GO:0001846) |
1.0 | 4.9 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.0 | 1.0 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
1.0 | 4.9 | GO:0001515 | opioid peptide activity(GO:0001515) |
1.0 | 2.9 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.0 | 3.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.0 | 4.9 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
1.0 | 2.9 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
1.0 | 4.8 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
1.0 | 2.9 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.0 | 4.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.0 | 1.0 | GO:0097027 | ubiquitin-protein transferase regulator activity(GO:0055106) ubiquitin-protein transferase activator activity(GO:0097027) |
1.0 | 11.5 | GO:0015643 | toxic substance binding(GO:0015643) |
1.0 | 3.8 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
1.0 | 2.9 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.9 | 3.8 | GO:0030984 | kininogen binding(GO:0030984) |
0.9 | 0.9 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.9 | 1.9 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.9 | 0.9 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.9 | 3.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.9 | 6.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.9 | 1.9 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.9 | 2.8 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.9 | 7.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.9 | 6.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.9 | 6.5 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.9 | 3.7 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.9 | 4.6 | GO:0070728 | leucine binding(GO:0070728) |
0.9 | 3.6 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.9 | 89.6 | GO:0019838 | growth factor binding(GO:0019838) |
0.9 | 7.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.9 | 0.9 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.9 | 2.7 | GO:0070061 | fructose binding(GO:0070061) |
0.9 | 3.5 | GO:0036122 | BMP binding(GO:0036122) |
0.9 | 0.9 | GO:0002054 | nucleobase binding(GO:0002054) |
0.9 | 0.9 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.9 | 1.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.9 | 1.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.9 | 3.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.9 | 0.9 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.9 | 0.9 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.9 | 0.9 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.9 | 2.6 | GO:0071253 | connexin binding(GO:0071253) |
0.9 | 2.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.9 | 5.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.9 | 1.7 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.9 | 1.7 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.9 | 0.9 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.8 | 1.7 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.8 | 25.0 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.8 | 1.7 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.8 | 10.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.8 | 1.7 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.8 | 2.5 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.8 | 1.7 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.8 | 15.7 | GO:0008483 | transaminase activity(GO:0008483) |
0.8 | 3.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.8 | 9.1 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.8 | 0.8 | GO:0052827 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.8 | 10.6 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.8 | 2.4 | GO:0015265 | urea channel activity(GO:0015265) |
0.8 | 26.7 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.8 | 4.0 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.8 | 2.4 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.8 | 6.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.8 | 0.8 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.8 | 2.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.8 | 3.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.8 | 12.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.8 | 27.0 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.8 | 1.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.8 | 2.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.8 | 2.4 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.8 | 0.8 | GO:0016015 | morphogen activity(GO:0016015) |
0.8 | 4.7 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.8 | 17.9 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.8 | 3.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.8 | 1.5 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.8 | 3.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.8 | 7.7 | GO:0019841 | retinol binding(GO:0019841) |
0.8 | 2.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.8 | 1.5 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.8 | 1.5 | GO:0019961 | interferon binding(GO:0019961) |
0.8 | 5.3 | GO:0018854 | acyl-CoA ligase activity(GO:0003996) 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.8 | 1.5 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.8 | 2.3 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.7 | 0.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.7 | 2.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.7 | 0.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.7 | 5.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.7 | 1.5 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.7 | 6.7 | GO:0003796 | lysozyme activity(GO:0003796) |
0.7 | 2.9 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.7 | 4.4 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.7 | 2.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.7 | 3.6 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.7 | 1.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.7 | 0.7 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.7 | 4.3 | GO:0034522 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.7 | 3.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.7 | 2.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.7 | 3.6 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.7 | 1.4 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.7 | 0.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.7 | 2.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.7 | 22.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.7 | 6.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.7 | 9.2 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.7 | 2.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.7 | 9.9 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.7 | 1.4 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.7 | 3.5 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.7 | 3.5 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.7 | 0.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.7 | 7.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.7 | 3.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.7 | 8.3 | GO:0031005 | filamin binding(GO:0031005) |
0.7 | 1.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.7 | 2.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.7 | 2.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.7 | 2.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.7 | 8.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.7 | 7.5 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.7 | 1.4 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.7 | 6.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.7 | 1.4 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.7 | 2.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.7 | 2.7 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.7 | 17.6 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.7 | 4.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.7 | 0.7 | GO:0009931 | calcium-dependent protein kinase C activity(GO:0004698) calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.7 | 2.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.7 | 0.7 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.7 | 4.6 | GO:0070403 | NAD+ binding(GO:0070403) |
0.7 | 2.6 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.7 | 2.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.7 | 0.7 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.6 | 3.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.6 | 7.1 | GO:0016208 | AMP binding(GO:0016208) |
0.6 | 12.2 | GO:0017069 | snRNA binding(GO:0017069) |
0.6 | 2.6 | GO:0016151 | nickel cation binding(GO:0016151) |
0.6 | 4.5 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.6 | 11.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.6 | 2.5 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.6 | 1.9 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.6 | 8.9 | GO:0005521 | lamin binding(GO:0005521) |
0.6 | 1.9 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.6 | 0.6 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.6 | 2.5 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.6 | 0.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.6 | 4.4 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.6 | 5.0 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.6 | 11.9 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.6 | 2.5 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.6 | 6.9 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.6 | 11.2 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.6 | 3.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.6 | 1.9 | GO:0030172 | troponin C binding(GO:0030172) |
0.6 | 6.8 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.6 | 16.5 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.6 | 6.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.6 | 17.7 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.6 | 5.5 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.6 | 0.6 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.6 | 3.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.6 | 9.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.6 | 5.4 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.6 | 1.8 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.6 | 11.3 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.6 | 3.6 | GO:0001848 | complement binding(GO:0001848) |
0.6 | 1.8 | GO:0043199 | sulfate binding(GO:0043199) |
0.6 | 7.1 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.6 | 5.3 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.6 | 9.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.6 | 2.3 | GO:0034618 | arginine binding(GO:0034618) |
0.6 | 2.9 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.6 | 2.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.6 | 2.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.6 | 4.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.6 | 2.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.6 | 1.7 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.6 | 3.4 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.6 | 5.1 | GO:0008253 | nucleotidase activity(GO:0008252) 5'-nucleotidase activity(GO:0008253) |
0.6 | 0.6 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.6 | 1.1 | GO:0004096 | catalase activity(GO:0004096) |
0.6 | 1.7 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.6 | 0.6 | GO:0070052 | collagen V binding(GO:0070052) |
0.6 | 2.8 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.6 | 2.2 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.6 | 1.1 | GO:0032564 | dATP binding(GO:0032564) |
0.5 | 2.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.5 | 1.6 | GO:0031014 | troponin T binding(GO:0031014) |
0.5 | 1.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.5 | 2.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.5 | 1.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.5 | 2.2 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.5 | 2.2 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.5 | 4.3 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.5 | 24.9 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.5 | 15.1 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.5 | 5.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.5 | 9.1 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.5 | 0.5 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.5 | 1.6 | GO:0004386 | helicase activity(GO:0004386) |
0.5 | 13.9 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.5 | 1.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.5 | 1.6 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.5 | 1.6 | GO:0048038 | quinone binding(GO:0048038) |
0.5 | 15.4 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.5 | 1.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.5 | 5.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.5 | 1.6 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.5 | 2.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.5 | 0.5 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.5 | 1.6 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.5 | 6.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.5 | 2.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.5 | 2.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.5 | 6.2 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.5 | 2.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.5 | 27.3 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.5 | 1.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.5 | 1.5 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.5 | 1.5 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.5 | 1.5 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.5 | 9.2 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.5 | 1.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.5 | 12.2 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.5 | 14.7 | GO:0005507 | copper ion binding(GO:0005507) |
0.5 | 1.0 | GO:0019862 | IgA binding(GO:0019862) |
0.5 | 1.5 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.5 | 2.5 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.5 | 3.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.5 | 5.5 | GO:0043274 | phospholipase binding(GO:0043274) |
0.5 | 1.5 | GO:0000182 | rDNA binding(GO:0000182) |
0.5 | 5.4 | GO:0044466 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.5 | 1.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.5 | 1.5 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.5 | 39.0 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.5 | 1.4 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.5 | 4.3 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.5 | 10.5 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
0.5 | 19.0 | GO:0000988 | transcription factor activity, protein binding(GO:0000988) |
0.5 | 1.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.5 | 1.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.5 | 6.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.5 | 15.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.5 | 3.3 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.5 | 0.9 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.5 | 0.9 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.5 | 1.4 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.5 | 1.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.5 | 9.7 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.5 | 0.9 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.5 | 9.2 | GO:0030145 | manganese ion binding(GO:0030145) |
0.5 | 1.8 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.5 | 1.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.5 | 2.7 | GO:0018499 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.5 | 7.7 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.5 | 4.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.5 | 4.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.4 | 1.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.4 | 2.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.4 | 6.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.4 | 1.8 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.4 | 0.4 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.4 | 1.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.4 | 2.2 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.4 | 3.5 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.4 | 2.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.4 | 3.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.4 | 3.5 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.4 | 2.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.4 | 17.8 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.4 | 0.9 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.4 | 7.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.4 | 1.7 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.4 | 1.3 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.4 | 12.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.4 | 2.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.4 | 4.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.4 | 4.2 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.4 | 0.8 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.4 | 0.8 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.4 | 1.3 | GO:0048030 | disaccharide binding(GO:0048030) |
0.4 | 2.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.4 | 1.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.4 | 1.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.4 | 1.7 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.4 | 15.4 | GO:0000049 | tRNA binding(GO:0000049) |
0.4 | 5.0 | GO:0001618 | virus receptor activity(GO:0001618) |
0.4 | 1.7 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.4 | 1.7 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.4 | 5.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.4 | 44.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.4 | 5.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.4 | 1.7 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.4 | 2.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.4 | 4.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.4 | 2.0 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.4 | 0.8 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.4 | 0.4 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.4 | 5.3 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.4 | 0.4 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.4 | 1.6 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.4 | 5.6 | GO:0043236 | laminin binding(GO:0043236) |
0.4 | 4.0 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.4 | 3.6 | GO:0052742 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) phosphatidylinositol kinase activity(GO:0052742) |
0.4 | 1.2 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.4 | 1.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.4 | 4.0 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.4 | 2.8 | GO:0080011 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.4 | 1.6 | GO:0017040 | ceramidase activity(GO:0017040) |
0.4 | 0.8 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.4 | 20.6 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.4 | 14.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.4 | 0.8 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.4 | 3.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.4 | 1.6 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.4 | 3.1 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.4 | 1.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.4 | 5.0 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.4 | 3.1 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.4 | 4.6 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.4 | 8.8 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.4 | 0.8 | GO:0019808 | polyamine binding(GO:0019808) |
0.4 | 4.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.4 | 0.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.4 | 1.1 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.4 | 18.6 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.4 | 3.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.4 | 1.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.4 | 1.5 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.4 | 3.0 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.4 | 0.4 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.4 | 5.2 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.4 | 0.7 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.4 | 4.1 | GO:0005123 | death receptor binding(GO:0005123) |
0.4 | 0.7 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.4 | 0.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.4 | 1.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.4 | 8.7 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.4 | 1.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.4 | 0.4 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.4 | 4.3 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.4 | 3.9 | GO:0009975 | cyclase activity(GO:0009975) |
0.4 | 1.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.4 | 1.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.4 | 1.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.4 | 4.2 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.4 | 0.7 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.4 | 3.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.4 | 0.4 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.3 | 0.3 | GO:0015927 | trehalase activity(GO:0015927) |
0.3 | 0.3 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.3 | 11.4 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.3 | 1.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.3 | 2.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.3 | 1.7 | GO:0031386 | protein tag(GO:0031386) |
0.3 | 1.0 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.3 | 0.7 | GO:0031433 | telethonin binding(GO:0031433) |
0.3 | 3.8 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.3 | 1.0 | GO:0002046 | opsin binding(GO:0002046) |
0.3 | 1.4 | GO:0035173 | histone kinase activity(GO:0035173) |
0.3 | 1.7 | GO:0070990 | snRNP binding(GO:0070990) U1 snRNP binding(GO:1990446) |
0.3 | 2.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.3 | 2.7 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.3 | 10.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.3 | 14.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.3 | 2.0 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.3 | 0.3 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.3 | 5.0 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 1.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.3 | 6.2 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.3 | 2.6 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.3 | 0.3 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.3 | 2.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 1.6 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.3 | 0.6 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.3 | 2.9 | GO:0043176 | amine binding(GO:0043176) |
0.3 | 25.5 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.3 | 3.9 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.3 | 1.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.3 | 0.6 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.3 | 1.9 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.3 | 1.6 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.3 | 6.7 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.3 | 3.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.3 | 0.3 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.3 | 0.6 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 3.8 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.3 | 0.6 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.3 | 4.7 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 3.1 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.3 | 17.6 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.3 | 0.3 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.3 | 1.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.3 | 1.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.3 | 3.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.3 | 11.3 | GO:0035064 | methylated histone binding(GO:0035064) |
0.3 | 0.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.3 | 0.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.3 | 0.3 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.3 | 0.6 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.3 | 1.5 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.3 | 1.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.3 | 1.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 0.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 1.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.3 | 0.9 | GO:0019002 | GMP binding(GO:0019002) |
0.3 | 1.5 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.3 | 2.0 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.3 | 24.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.3 | 2.6 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.3 | 2.9 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.3 | 16.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.3 | 0.9 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.3 | 8.6 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.3 | 0.9 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.3 | 2.8 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.3 | 8.8 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.3 | 1.7 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.3 | 9.9 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.3 | 4.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.3 | 3.4 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.3 | 15.8 | GO:0000149 | SNARE binding(GO:0000149) |
0.3 | 2.5 | GO:0008061 | chitin binding(GO:0008061) |
0.3 | 0.6 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.3 | 18.5 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.3 | 0.8 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.3 | 0.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.3 | 6.7 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.3 | 0.6 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.3 | 1.4 | GO:0015288 | porin activity(GO:0015288) |
0.3 | 0.6 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.3 | 1.9 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 2.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.3 | 4.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 8.1 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.3 | 0.8 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 9.2 | GO:0031267 | small GTPase binding(GO:0031267) |
0.3 | 1.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 2.1 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.3 | 1.6 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.3 | 0.5 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.3 | 1.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.3 | 1.8 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.3 | 0.3 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 4.1 | GO:0030515 | snoRNA binding(GO:0030515) |
0.3 | 4.4 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.3 | 4.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.3 | 0.8 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 11.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.3 | 1.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.3 | 2.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.3 | 1.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.2 | 0.7 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.2 | 1.0 | GO:0016421 | CoA carboxylase activity(GO:0016421) ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.2 | 0.7 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 0.7 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.2 | 1.0 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 0.7 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.2 | 1.0 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.2 | 4.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.2 | 1.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 4.2 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) cis-trans isomerase activity(GO:0016859) |
0.2 | 0.7 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 6.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 1.0 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 4.8 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 0.7 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 0.7 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 0.7 | GO:0004103 | choline kinase activity(GO:0004103) |
0.2 | 0.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 0.2 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.2 | 0.9 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 0.2 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.2 | 2.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 2.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 5.7 | GO:0008009 | chemokine activity(GO:0008009) |
0.2 | 0.2 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.2 | 0.7 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 0.9 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 39.6 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 0.9 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 0.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 0.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 6.4 | GO:0016874 | ligase activity(GO:0016874) |
0.2 | 11.2 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.2 | 0.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 1.7 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.2 | 0.7 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 0.7 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.2 | 0.4 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 1.7 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 11.6 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.2 | 0.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.2 | 0.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 1.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 1.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 0.6 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 1.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 1.6 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.2 | 1.4 | GO:0061134 | peptidase regulator activity(GO:0061134) |
0.2 | 1.0 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.2 | 1.6 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.2 | 0.8 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 0.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 1.6 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.2 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 1.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 0.6 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.2 | 0.4 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.2 | 2.5 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 1.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 32.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 0.2 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.2 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 1.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.2 | 8.2 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.2 | 8.9 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 0.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 2.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.2 | 3.8 | GO:0016209 | antioxidant activity(GO:0016209) |
0.2 | 0.8 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 0.2 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.2 | 1.3 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 3.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 0.6 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.2 | 2.8 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.2 | 0.2 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.2 | 0.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 0.7 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.2 | 0.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 1.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.2 | 1.8 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 0.9 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.2 | 0.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 1.7 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.2 | 1.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 0.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.2 | 0.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.2 | 1.2 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.2 | 0.5 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 4.0 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.2 | 1.0 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 0.7 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.2 | 0.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 1.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 4.7 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.2 | 0.5 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 1.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 2.8 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 0.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 1.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.2 | 0.8 | GO:1990405 | protein antigen binding(GO:1990405) |
0.2 | 0.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 0.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 0.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 22.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 0.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 0.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 1.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 0.3 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.2 | 0.6 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.2 | 5.3 | GO:0008134 | transcription factor binding(GO:0008134) |
0.2 | 1.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 13.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 0.9 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.2 | 1.9 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.2 | 1.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 0.2 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) tRNA guanylyltransferase activity(GO:0008193) |
0.1 | 8.5 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 3.2 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.9 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 1.0 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.1 | 1.0 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.3 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 5.1 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.1 | 0.3 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.4 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.8 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 2.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 1.8 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 9.0 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.1 | 0.1 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.1 | 2.7 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 0.3 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 1.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.7 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.3 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 2.2 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.5 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 14.7 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 1.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.8 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 7.7 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 4.5 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.3 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.3 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.1 | 0.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.7 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.1 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 1.6 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 0.2 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 3.3 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.1 | 0.1 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.1 | 0.1 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.1 | 7.2 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 1.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 1.1 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.1 | 1.5 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 3.6 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.1 | GO:0046977 | TAP binding(GO:0046977) |
0.1 | 0.9 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 1.0 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 0.7 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 1.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.1 | GO:0097617 | annealing activity(GO:0097617) |
0.1 | 0.1 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.1 | 0.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.1 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
0.1 | 0.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.1 | 0.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.7 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.7 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 1.9 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.4 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 0.2 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.3 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.3 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 0.1 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 0.3 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 0.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 1.4 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 1.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 5.5 | GO:0005126 | cytokine receptor binding(GO:0005126) |
0.1 | 0.5 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 1.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 1.5 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.1 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.1 | 20.0 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 0.1 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 3.2 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 0.4 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 56.0 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 21.7 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.0 | 0.0 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.3 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
0.0 | 1.2 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.0 | 1.2 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.3 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.9 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.0 | 0.9 | GO:0004527 | exonuclease activity(GO:0004527) |
0.0 | 0.2 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.0 | 7.1 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 1.0 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 3.8 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.3 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.0 | 0.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 2.7 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.2 | GO:0030695 | GTPase regulator activity(GO:0030695) nucleoside-triphosphatase regulator activity(GO:0060589) |
0.0 | 0.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.1 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.4 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.0 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.0 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.0 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) |
0.0 | 0.0 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.0 | 18.7 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.4 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
0.0 | 0.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.0 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.0 | 0.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.1 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.7 | GO:0044389 | ubiquitin-like protein ligase binding(GO:0044389) |
0.0 | 0.0 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.7 | 97.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
1.8 | 3.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.6 | 9.6 | ST STAT3 PATHWAY | STAT3 Pathway |
1.6 | 3.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.6 | 7.9 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
1.3 | 53.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.2 | 3.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
1.2 | 26.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
1.1 | 13.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.1 | 4.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.1 | 9.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.1 | 16.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.0 | 4.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.0 | 3.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
1.0 | 9.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.0 | 19.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.9 | 10.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.9 | 14.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.9 | 17.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.9 | 8.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.9 | 21.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.9 | 28.0 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.9 | 25.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.9 | 12.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.9 | 8.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.9 | 33.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.8 | 10.8 | PID IFNG PATHWAY | IFN-gamma pathway |
0.8 | 22.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.8 | 6.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.8 | 14.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.8 | 14.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.7 | 39.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.7 | 17.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.7 | 1.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.7 | 2.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.7 | 23.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.7 | 2.8 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.7 | 31.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.7 | 2.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.6 | 7.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.6 | 18.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.6 | 26.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.6 | 1.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.6 | 7.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.6 | 6.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.6 | 18.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.6 | 1.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.5 | 9.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.5 | 4.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.5 | 10.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.5 | 4.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.5 | 9.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.5 | 6.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.5 | 7.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.5 | 5.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.5 | 13.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.5 | 3.8 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.5 | 11.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.5 | 14.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.5 | 2.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.5 | 3.7 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.5 | 13.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.5 | 1.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.5 | 5.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.4 | 8.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.4 | 1.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.4 | 12.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.4 | 2.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.4 | 7.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.4 | 7.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.4 | 5.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.4 | 3.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.4 | 3.7 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.4 | 2.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.4 | 30.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.4 | 15.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.4 | 1.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.4 | 1.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.4 | 2.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.4 | 50.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.4 | 0.7 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.4 | 70.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.4 | 0.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.3 | 4.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.3 | 6.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 0.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.3 | 1.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 3.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.3 | 3.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.3 | 1.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 4.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 1.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.3 | 0.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 0.6 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.3 | 9.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.3 | 3.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.3 | 5.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.3 | 5.5 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.3 | 0.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.3 | 0.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 2.2 | PID FOXO PATHWAY | FoxO family signaling |
0.3 | 9.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.3 | 1.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.3 | 5.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.3 | 1.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 3.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.3 | 3.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 1.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 0.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 1.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 8.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 4.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 2.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 2.8 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 2.9 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.2 | 0.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 1.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 3.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 0.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 2.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 1.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 0.9 | PID ATM PATHWAY | ATM pathway |
0.2 | 5.1 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 3.3 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 0.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 0.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 1.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 3.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 3.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.7 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 1.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.7 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 0.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 0.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 1.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.7 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 2.1 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 1.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 1.1 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 1.3 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 3.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
3.0 | 24.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
2.6 | 26.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
2.3 | 22.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
2.2 | 4.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
2.0 | 12.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.9 | 21.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
1.9 | 34.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.7 | 31.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
1.6 | 16.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.6 | 3.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.5 | 14.9 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.4 | 16.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
1.3 | 30.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.3 | 9.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
1.3 | 14.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
1.3 | 19.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.3 | 13.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.3 | 16.4 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
1.2 | 19.8 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.2 | 27.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
1.2 | 4.9 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.2 | 18.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.2 | 21.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
1.2 | 13.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.2 | 6.9 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.1 | 5.7 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
1.1 | 15.9 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
1.1 | 12.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
1.1 | 17.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.1 | 11.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
1.1 | 16.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
1.1 | 30.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
1.1 | 13.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
1.1 | 10.8 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
1.1 | 14.0 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
1.1 | 11.7 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
1.1 | 21.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
1.1 | 14.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.0 | 11.1 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
1.0 | 24.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.9 | 13.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.9 | 10.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.9 | 15.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.9 | 7.8 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.8 | 3.4 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.8 | 4.1 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.8 | 22.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.8 | 8.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.8 | 9.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.8 | 23.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.8 | 4.6 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.8 | 32.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.8 | 4.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.8 | 6.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.8 | 5.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.7 | 7.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.7 | 8.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.7 | 2.9 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.7 | 4.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.7 | 11.4 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.7 | 7.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.7 | 7.0 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.7 | 11.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.7 | 16.5 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.7 | 1.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.7 | 4.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.7 | 5.4 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.7 | 2.7 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.7 | 2.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.7 | 21.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.7 | 9.1 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.6 | 15.5 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.6 | 1.3 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.6 | 7.0 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.6 | 4.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.6 | 3.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.6 | 6.8 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.6 | 6.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.6 | 9.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.6 | 13.8 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.6 | 50.4 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.6 | 3.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.6 | 8.1 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.6 | 7.9 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.6 | 5.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.6 | 34.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.6 | 37.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.6 | 10.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.5 | 2.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.5 | 13.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.5 | 11.9 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.5 | 5.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.5 | 1.6 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.5 | 1.1 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.5 | 2.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.5 | 2.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.5 | 2.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.5 | 1.6 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.5 | 4.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.5 | 12.8 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.5 | 5.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.5 | 5.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.5 | 3.1 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.5 | 7.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.5 | 8.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.5 | 14.6 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.5 | 1.4 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.5 | 6.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.5 | 29.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.5 | 25.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.5 | 2.7 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.5 | 6.9 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.5 | 54.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.5 | 5.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.5 | 5.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.5 | 5.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.4 | 3.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.4 | 7.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.4 | 1.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.4 | 16.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.4 | 4.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.4 | 16.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.4 | 14.5 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.4 | 6.6 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.4 | 3.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.4 | 18.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.4 | 2.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.4 | 2.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.4 | 2.0 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.4 | 2.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.4 | 0.4 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.4 | 8.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.4 | 2.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.4 | 10.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.4 | 3.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.4 | 28.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.4 | 4.0 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.4 | 11.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.4 | 0.4 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.4 | 4.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.4 | 5.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.4 | 6.7 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.4 | 2.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.3 | 13.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.3 | 10.0 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.3 | 5.4 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.3 | 5.1 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.3 | 3.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.3 | 2.3 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
0.3 | 2.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.3 | 1.0 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.3 | 18.5 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.3 | 5.1 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.3 | 2.5 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.3 | 7.5 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.3 | 8.2 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.3 | 5.2 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.3 | 2.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.3 | 16.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.3 | 12.5 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.3 | 0.3 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.3 | 1.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.3 | 4.4 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.3 | 2.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 1.6 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.3 | 2.6 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.3 | 1.0 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.3 | 1.3 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.3 | 2.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 0.8 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.3 | 3.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 5.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.2 | 5.5 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.2 | 0.5 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.2 | 4.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 2.4 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.2 | 6.7 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.2 | 2.2 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.2 | 2.9 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 3.1 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 0.9 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 0.5 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 0.9 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 2.8 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 0.5 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.2 | 4.7 | REACTOME PHOSPHOLIPID METABOLISM | Genes involved in Phospholipid metabolism |
0.2 | 0.2 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.2 | 0.7 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.2 | 11.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 3.5 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.2 | 3.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 0.9 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.2 | 0.8 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.2 | 2.8 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 1.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 0.6 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 3.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 8.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 8.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 0.8 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 3.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 5.2 | REACTOME TRANSLATION | Genes involved in Translation |
0.2 | 0.7 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 1.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 18.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.2 | 0.5 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.2 | 3.0 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.2 | 0.7 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 0.7 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.2 | 0.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 1.8 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 0.8 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 1.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 1.2 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 0.6 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.1 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 0.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 3.6 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 1.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.8 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 2.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.6 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 1.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 0.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 1.5 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.1 | 0.6 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 1.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 1.9 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 2.0 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 2.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 3.4 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.1 | 0.1 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 2.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 0.4 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.0 | 0.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.1 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.2 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.8 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 1.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.0 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.0 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |